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Background: The enzyme, 1-pyrroline-5-carboxylate dehydrogenase (P5CDH), is a key enzyme involved in proline
catabolism.
Results: The parasite Trypanosoma cruzi up-regulates P5CDH during host infection.
Conclusion: T. cruzi uses P5C to produce energy, resist metabolic stress, and invade host cells through this mitochondrion-
bound enzyme.
Significance: The oxidation of P5C is sufficient to supply energy and enhance the pathogenicity of T. cruzi.
Proline is crucial for energizing critical events throughout the
life cycle of Trypanosoma cruzi, the etiological agent of Chagas
disease. The proline breakdown pathway consists of two oxida-
tion steps, both of which produce reducing equivalents as fol-
lows: the conversion of proline to 1-pyrroline-5-carboxylate
(P5C), and the subsequent conversion of P5C to glutamate. We
have identified and characterized the 1-pyrroline-5-carboxy-
late dehydrogenase from T. cruzi (TcP5CDH) and report here
on how this enzyme contributes to a central metabolic pathway
in this parasite. Size-exclusion chromatography, two-dimen-
sional gel electrophoresis, and small angle x-ray scattering anal-
ysis of TcP5CDH revealed an oligomeric state composed of two
subunits of six protomers. TcP5CDHwas found to complement
a yeast strain deficient in PUT2 activity, confirming the
enzyme’s functional role; and the biochemical parameters (Km,
kcat, and kcat/Km) of the recombinant TcP5CDH were deter-
mined, exhibiting values comparable with those from T. cruzi
lysates. In addition,TcP5CDHexhibitedmitochondrial staining
during themain stages of theT. cruzi life cycle.mRNAand enzy-
matic activity levels indicated the up-regulation (6-fold change)
of TcP5CDHduring the infective stages of the parasite. The par-
ticipation of P5C as an energy source was also demonstrated.
Overall, we propose that this enzymatic step is crucial for the
viability of both replicative and infective forms of T. cruzi.
Protozoan parasites include several species responsible for a
number of major health problems affecting humans and live-
stock as well as wild and domesticated animals. Organisms
belonging to the genera Trypanosoma, Leishmania, and Plas-
modium are clinically relevant and serve asmodels for studying
the adaptation strategies of unicellular organisms to different
environments. Changes in organelle composition, the regula-
tion of gene expression and “metabolic architecture,” among
other adaptations, can greatly affect the success of the survival
strategies of these organisms. Trypanosoma cruzi is a vector-
borne hemoflagellate that can infect humans and cause Chagas
disease, one of the 13 diseases classified by the World Health
Organization as “neglected diseases” that affect 8–10 million
people and cause 10 thousand deaths per year worldwide (1–3).
Natural transmission of T. cruzi occurs via its parasitic coloni-
zation of a blood-sucking triatomine insect (popularly known
as the kissing bug), followed by its passage into the insect
excreta, which subsequently passes the infective form of the
parasite to amammalian host (e.g. humans) (2, 4). Additionally,
evidence of outbreaks attributed to vector-excreta-contami-
nated food indicates the oral transmission of T. cruzi (5, 6).
Recently, the World Health Organization warned that Chagas
disease has become a more serious health problem due to its
spread from endemic areas (south of the United States to
Argentina and Chile) to nonendemic countries (3).
Because T. cruzi lives in different environments throughout
its life cycle (i.e. the different regions of the insect host digestive
tube and the intra- and extracellular media in different mam-
malian tissues), it is exposed to various temperatures, ion com-
positions, redox states, pH, and metabolic conditions (7).
Therefore, the parasite must adapt to these changing habitats
for survival, proliferation, and eventually differentiation. For
example, the ability to switch from a carbohydrate-based to an
amino acid-based metabolism requires cellular versatility to
enable the organism to copewith the challenges associatedwith
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the composition of available food sources (8). InT. cruzi, as well
as in other organisms, proline has been shown to sufficiently
provide cellular energy requirements. Specifically, the proline
metabolism of T. cruzi has been found to be involved in oxygen
consumption, resistance to osmotic andmetabolic stresses, and
oxidative imbalance (9–11). In addition, in this parasite, pro-
line has been shown to be involved in several energy-consum-
ing processes, such as cellular differentiation and host cell inva-
sion (12–15).
Proline breakdown occurs via two enzymatic redox steps and
one nonenzymatic reaction, producing glutamate and reduced
equivalents (16, 17). First, proline is converted to 1-pyrroline-5-
carboxylate (P5C)2 through a FAD (cofactor)-dependent reaction
that is catalyzed by a proline dehydrogenase (TcProDH) (EC
1.5.99.8) (10). The subsequent step involves a nonenzymatic
reaction in which the cyclic P5C ring is spontaneously opened,
producing glutamate--semialdehyde (GS) (18). The carbonyl
moiety of GS is further oxidized to glutamic acid by1-pyrro-
line-5-carboxylate dehydrogenase (TcP5CDH) (EC 1.5.1.12)
with a concomitant reduction of NAD(P) to NAD(P)H (19).
P5CDH has been characterized in distinct prokaryote and
eukaryote species. However, no direct evidence supports the
existence of this key enzyme in protozoan organisms. In other
organisms, both enzymes (ProDH and P5CDH) have been
reported to be associated with the mitochondria (20, 21). In
yeast, rat, and human cells, these enzymes are localized within
the mitochondrial matrix (22–24). In the case of Zea mays,
these enzymes appear to be bound to the mitochondrial inner
membrane (21). In addition, structural studies have revealed
that these types of enzymes undergo oligomerization that can
vary from two to six protomers (25–27).
The hemoflagellate cells of the Kinetoplastid order harbor a
single well developed mitochondrion that spans the entire cell
body and is distributed in branches under the subpellicular
microtubules (28). This particular organelle is composed of
classical mitochondrial compartments (the outer and inner
membranes, the intermembrane space, and the matrix) that
exhibit a particular structure known as the kinetoplast, which
includes an intercatenated DNA network that includes the
mitochondrial genome (29, 30). Depending on the environ-
mental conditions, the mitochondrion can occupy a variable
amount of the total cellular volume (29). With regard to the
electron transport machinery, the presence of functional com-
plexes II to IV, as well as the F0/F1-ATPase, has been consis-
tently demonstrated (7).
The connection between proline metabolism andmitochon-
drial activity is well established (20, 21, 24). This relationship
has also been confirmed in several pathogenic trypanosomatids
(10, 31). However, there is no evidence to indicate a role for
P5CDH in mitochondrial functions. In plant and yeast cells,
altered P5Cmetabolism triggers a redox imbalance that results
in cell death (20, 32). In particular, Saccharomyces cerevisiae
acetylates P5C via anMPR1-mediated pathway as a detoxifying
mechanism against oxidative injury (32). In CHO-K1 cells, P5C
was shown to be involved in redoxmetabolismby up-regulating
the hexose monophosphate shunt pathway (33). Farrant et al.
(35) assessed the response of patients with P5CDH deficiency,
which was previously reported as an inborn error of metabo-
lism (hyperprolinemia type II), and showed that an increased
intracellular P5Cpool chemically inhibits vitaminB6 (pyridoxal
5-phosphate) (34), which is an essential prosthetic group of
transaminases. Taken together, these data suggest that the pro-
line-glutamate interconversion pathway participates in rele-
vant physiological processes and that the altered equilibrium of
their components might elicit detrimental effects beginning at
the mitochondrial level and leading to cell death.
Previous biochemical data suggested that glutamate is bio-
synthesized via a proline oxidation pathway (9). The first enzy-
matic step of this pathway consists of the conversion of proline
into P5C, as has been recently elucidated (10). In this study, we
provide conclusive biochemical, mechanistic, and molecular
evidence of the functionality of TcP5CDH in several aspects of
theT. cruzi life cycle.We show the involvement of TcP5CDH in
mitochondrial processes and its developmental expression in
distinct parasite stages. These data provide new insights into
the proline oxidation pathway as an efficient mechanism for
supplying energy to the pathogenic protozoa T. cruzi. The
potential for using this enzyme as a drug target is also discussed.
EXPERIMENTAL PROCEDURES
Ethics Statement
Animals were used to obtain a polyclonal monospecific serum
against a recombinant protein. The protocol was approved by the
ethical committee for animal use in research of the Institute of
Biomedical Sciences at University of São Paulo. All procedures
followed Brazilian regulations and were approved under protocol
number 017/2008.
Microorganisms and Culture
Parasites—The epimastigote (E) forms of T. cruzi (CL strain,
clone 14) were cultured at 28 °C by successive passages in unde-
fined medium (LIT) supplemented with 10% (v/v) heat-inacti-
vated fetal calf serum (FCS) (Vitrocell, Campinas, SP, Brazil)
(36). Metacyclic trypomastigotes (M) were obtained from 5 
108 epimastigote cells in the stationary growth phase (4th day),
washed once with saline phosphate buffer 1 (PBS), and trans-
ferred to Grace’s medium, pH 6.0 (Gibco, Life Technologies)
for in vitro differentiation over 9 days at 28 °C. The metacyclic
trypomastigotes were further purified using ion-exchange
chromatography in diethylaminoethylcellulose columns as
described previously (37). Intracellular forms were collected
from mammalian tissue culture cell-derived trypomastigotes
(TCTs) in Chinese hamster ovary cells (CHO-K1) cultivated in
2 The abbreviations used are: P5C, 1-pyrroline-5-carboxylate; P5CDH,
1-pyrroline-5-carboxylate dehydrogenase; SAXS, small angle x-ray scat-
tering; TcP5CDH,1-pyrroline-5-carboxylate dehydrogenase from T. cruzi;
proline dehydrogenase from T. cruzi; NGE, native gel electrophoresis; GS,
glutamate--semialdehyde; SEC, size-exclusion chromatography; DDM,
dodecyl maltoside; OAB, o-aminobenzaldehyde; TCT, tissue culture cell-
derived trypomastigote; CHES, 2-(cyclohexylamino)ethanesulfonic acid;
BNGE, blue native gel electrophoresis; DLS, dynamic light scattering; GS,
glutamate -semialdehyde; DIG, digitonin; E, epimastigote; M, metacyclic
trypomastigote; A, amastigote; Ie, intracellular epimastigote; TCT, trypo-
mastigote; TcTAT, tyrosine aminotransferase; MTT, 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide; TcASATm, mitochondrial aspar-
tate aminotransferase; Mc, mitochondrial; Te, total extract; CS, citrate
synthase; mTP, mitochondria target peptide.
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RPMI 1640 medium supplemented with 10% FCS, 0.15%
NaHCO3 (w/v), 100 units ml1 penicillin, and 100 mg ml1 of
streptomycin in a humid atmosphere containing 5% CO2. A
parasite/cell ratio of 50 trypomastigotes per CHO-K1 cell was
used for infection assays. Amastigotes (A), intracellular epimas-
tigotes (IE), and TCT forms were isolated on the 2nd, 4th, and
7th days post-infection, respectively (13). Cell numbers were
counted using a Neubauer chamber.
Bacteria—The Escherichia coli strain DH5-was used for all
cloning procedures. The cells were grown at 37 °C in Luria-
Bertani (LB)medium supplemented with 100gml1 ampicil-
lin and/or 2% agar base (w/v).
Yeast Manipulations—The S. cerevisiae strain S288c was
used as the wild-type strain for functional complementation
assays. The yeast mutant YHR037w (harboring a disruption
within the PUT2 gene) is a homozygous haploid derived from
the BY4741 strain (Euroscarf, Germany). This latter strain was
used in a systematic deletion project and is derived from the
parental S288c strain (38). YHR037w has a kanamycin resis-
tance cassette (KANMX4) flanking the PUT2 gene (YHR07w::
KANMX4), resulting in a deficient strain for P5CDH activity.
Aiming to restore the auxotrophies for histidine and leucine in
themutant YHR037w, their intrinsic deletionswere reverted by
introducing the LEU2 and HIS3 ORFs. All of the transforma-
tion procedures were performed as described previously (39).
The yeast strains were grown either in rich or selective media.
The rich media (YPD-2) contained 20 g liter1 yeast extract,
40 g liter1 peptone, 40 g liter1 D-glucose, and 2% agar base
(w/v) when necessary. The PUT2, control, and TcP5CDH
strains were maintained in the presence of 300 gml1 gene-
ticin (G418). After transformations, the cells were grown in
synthetic complete dropoutmedium (SC-gal), which contained
0.17% yeast nitrogen bases without amino acids or ammonium
sulfate (w/v), 0.5% ammonium sulfate (w/v), 2% galactose (w/v),
and dropout powder containing all amino acids except for his-
tidine, leucine, methionine, and uracil, as described previously
(40). Functional analysis was performed in synthetic depleted
(SD-gal) media, which contained 0.17% yeast nitrogen bases
without amino acids or ammonium sulfate (w/v), 2% galactose,
40 gml1 methionine, and either 10 mM proline or 0.5% urea
(w/v) as the only nitrogen source.
In Silico Analysis
Amino acid sequences for P5CDHs from distinct species
were aligned using the ClustalW tool under default parameters
and were manually checked (41). Sequences were retrieved from
UniProtKB database, and the access code numbers are indicated
within parentheses as follows: Homo sapiens (P30038), Mus
musculus (Q8CHT0), T. cruzi (Q4DRT8), Trypanosoma bru-
cei (Q38BS5), Leishmania major (Q9NKR5), S. cerevisiae
(P07275), E. coli (P5CDH domain between residues 623 and
1106 of P09546), Thermus thermophilus (Q72IB9), and Arabi-
dopsis thaliana (Q8VZC3). Signal peptides, transmembrane
domains, and -helix predictions were performed using the
phobius and heliQuest tools (, respectively, under default
parameters. The identification of transmembrane domains was
performed with the InterProScan database using the region
between residues Trp-180 and Ser-300 of the TcP5CDH
sequence.
Cloning Procedures
The full-length ORF encoding for 1-pyrroline-5-carboxy-
late dehydrogenase (identification number in the TriTryp data-
base, Tc00.1047053510943.50) was amplified by PCR using 10
ng of total epimastigote genomic DNA as a template, 1 unit of
Taq-DNA polymerase (Fermentas), 1.5 mM MgCl2, 0.25 mM
dNTPs mix, 1 Taq buffer with KCl, and 20 pmol of each oli-
gonucleotide. The gene-specific primers were designed with
restriction sites for the enzymes BamHI and XhoI, which are
underlined, as follows: Tcp5cdhFw 5-GGATCCATGTTACG-
TCGCACACTGC-3 and Tcp5cdhRv 5-CTCGAGCTAAAC-
AAACAGGCGGTC-3. The PCR conditions were as follows:
temperature of 95 °C (2 min) and 35 cycles of an initial dena-
turation at 92 °C (1 min), annealing at 61 °C (30 s), and elonga-
tion at 72 °C (2 min), with a final extension at 72 °C (10 min). A
single fragment of expected size (1.7 kb) was amplified and
cloned into the pCR-2.1 TOPO vector (Invitrogen) according
to the manufacturer’s instructions. To express recombinant
TcP5CDH in the bacteria, the ORF TcP5CDH was amplified
using a reverse primer in which the stop codon was removed.
The PCRproductwas digested using BamHI andXhoI enzymes
and ligated into the pET28a () expression vector (Novagen),
which was previously digested using the same restriction
enzymes. This construct allows for the recombinant expression
of a C-terminal His6-tagged fusion protein.
For functional assays in the yeast model, the circularized
plasmid pYEp351 harboring the LEU2 gene was introduced
into the PUT2 strain, resulting in PUT2-LEU2 (42). The
ORF encoding for HIS3 was released from the pMA210 vector
(43) by endonuclease digestion with BamHI and subsequently
inserted into the same site of the pYES2 polylinker region
(Invitrogen). The resulting pYES-HIS3 construct was then
inserted into the PUT2-LEU2, producing the PUT2-
LEU2HIS3URA3 strain (herein referred to as the “control
strain”). The TcP5CDH ORF was excised from the pCR-2.1
TOPO vector and cloned into the BamHI and XhoI sites of
pYES2 to produce the pYES-TcP5CDH construct. Next, the
control strain was transformedwith pYES-TcP5CDH, resulting
in the PUT2-LEU2 HIS3 URA3 TcP5CDH (TcP5CDH)
strain. All of the constructs were confirmed by DNA
sequencing.
Analysis of Recombinant TcP5CDH
Bacterial Expression of TcP5CDH—Aplasmid construct con-
taining TcP5CDH (pET28-TcP5CDH) was used to transform
E. coli BL21 (DE3) cells (Stratagene) that were previously
transformed with the pGro7 plasmid (Takara). This vector
contains a chaperone system that is expressed upon the addi-
tion of arabinose. Bacterial cells were grown in LB medium
containing chloramphenicol 20 gml1 and kanamycin 30
gml1 at 37 °C. When an absorbance (A) 600 nm  0.4 was
reached, 0.5 mgml1 L-arabinose was added to induce chaper-
one expression. Subsequently, when an A 600 nm of 0.6 was
reached, the expression of TcP5CDH-His6 was induced upon
the addition of 200 M isopropyl -D-thiogalactopyranoside,
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and the cultures were incubated for 4 h at 28 °C under constant
agitation (200 rpm). The recombinant TcP5CDH-His6 enzyme
was purified by metal-chelate affinity chromatography using a
Ni2-nitriloacetic acid (column (Qiagen). The TcP5CDH-His6
was eluted using 250 mM imidazole and dialyzed against
P5CDH buffer (50 mM HEPES-NaOH, 150 mM NaCl, 0.5 mM
EDTA, 0.5 mM tris(2-carboxyethyl)phosphine, 5% glycerol
(v/v), 0.02% n-dodecyl -D-maltoside (DDM) (w/v), pH 8.1).
The protein was further concentrated within a range of 0.3–2.5
mgml1 using the Centricon (molecularmass cutoff of 10 kDa)
centrifugation system (Millipore). Protein homogeneity was
assessed by SDS-PAGE (44), and protein concentrations were
determined with the Bradford method using bovine serum
albumin as a standard (45).
Polyclonal Serum Production—Tyrosine aminotransferase
(TcTAT) and aspartate aminotransferase (TcASATm) were
kindly provided by Dr. Cristina Nowicki (Faculty of Pharmacy
and Biochemistry, University of Buenos Aires, Argentina) (46–
48). Recombinant glyceraldehyde-3-phosphate dehydrogenase
(TcGAPDH) was obtained as reported previously (49). All of
these proteins, aswell as the recombinantTcP5CDH,were used
as immunogens to produce polyclonal antibodies in mice
according to standard protocols (50).
Oligomeric StateDetermination of TcP5CDH—Todetermine
the molecular mass of TcP5CDH under nondenaturing condi-
tions, the recombinant protein was dialyzed against P5CDH-
buffer and fractionated using a Superdex 200TM 16/60 GL col-
umn (Amersham Biosciences) coupled to an ÄKTA purifier
system (GE Healthcare). The column was previously equili-
brated with P5CDH buffer and run at a flow rate of 0.8
mlmin1. Fractions in which protein content was detected (by
absorbance at 280 nm) were pooled (1 ml) and further analyzed
by SDS-PAGE. Stokes radius and elution volumeswere used for
the determination of molecular size and compared with
dynamic light scattering (DLS) data. DLS measurements were
performed on a Zetasizer V (Malvern) reader at 10 °C in a
10-l cuvette.
Small angle x-ray scattering (SAXS) data were collected on
the SAXS2 beamline at the Brazilian Synchrotron Light Labo-
ratory. Scatteringwas recordedwithin the range of themomen-
tum transfer 0.014	 q	 0.34 Å1, where q 4sin/; 2 is
the scattering angle, and   1.48 Å is the x-ray wavelength.
The measurements were performed under vacuum with expo-
sure times of 5 min to decrease parasitic scattering. TcP5CDH
scattering was measured at a concentration of 2.5 mg ml1 in
P5CDH buffer (without surfactant) in the absence of ligand.
SAXS analysis was performed using the ATSAS program pack-
age (51). The distance distribution function p(r) and the radius
of gyration (Rg) were evaluated using the indirect Fourier trans-
form program GNOM (52). Molecular weight was evaluated
from SAXS curves using SAXSmoW (53). The low resolution
dummy residues models of TcP5CDH were restored from
experimental data using ab initiomodeling implemented in the
GASBOR program (54). CRYSOL (55) was used to evaluate the
simulated SAXS curve and crystallographic structure parame-
ters (Protein Data Bank code 1UZB). The ab initio low resolu-
tion models and the crystallographic structure were superim-
posed using the SUPCOMB program (56).
Subcellular Localization of TcP5CDH
Immunofluorescence Microscopy—Immunofluorescence assays
were performed to assess the predominant T. cruzi life cycles
(epimastigotes, metacyclic trypomastigotes, amastigotes, and
trypomastigotes derived from cell infections) by assessing the
co-localization of TcP5CDH with the mitochondrial Mito-
Tracker-CMXROS probe (Invitrogen). Briefly, parasite forms
(5  106 cells) were preincubated at 28 °C for stages E and M,
33 °C for stages A and IE, and 37 °C for TCT (30 min) in the
presence of 50 nM MitoTracker, which was dissolved in the
corresponding culture medium. An additional in situ assay
using CHO-K1 cells infected with TCTs was also performed.
Thus, CHO-K1 cells (4 105 cells/well) were layered in a sterile
glass slip embedded into 24-well plates for 24 h at 37 °C under a
5%CO2 atmosphere.Next, the cells were infectedwith theTCT
forms (2  107 per well) and cultured for 48 h at 33 °C for
preincubation with MitoTracker as described above. The cells
were harvested, washed twice with PBS, and seeded onto poly-
L-lysine-coated coverslips. The cells were fixed (20 min) with
4% p-formaldehyde (w/v) in PBS, permeabilized (5 min) by the
addition of 0.1% Triton X-100, and blocked (30 min) with 2%
BSA dissolved in PBS (PBS/BSA). The preparations were incu-
bated for 1 h at room temperature with anti-TcP5CDH (diluted
1:150 in PBS/BSA), washed five times with PBS, and further
incubated (50 min, light-protected) with AlexaFluor488-cou-
pled goat anti-mouse immunoglobulinG (Invitrogen) second-
ary antibody (1:400). DNA was stained by a further incubation
(1 min) with Hoechst 33258 probe (1:2500 in PBS) (Invitro-
gen). The coverslips were visualized using an Axio Imager
motorized M.2 (Carl Zeiss) epifluorescence microscope.
Microscope Z-sections were processed and merged using
ImageJ version 1.4p (National Institutes of Health) software for
a 64-bit iOS system.
Digitonin Titration—Selective digitonin permeabilization of
the T. cruzi epimastigote forms was performed as described
previously (46). Briefly, cell pellets (60 mg) were harvested and
resuspended in 1 ml of TSB buffer (25 mM Tris-HCl, pH 7.6,
0.25M sucrose, 1mMEDTA, 1mMPMSF, and 50l of protease/
inhibitor mixture from Sigma) in the presence of increasing
concentrations of digitonin (ranging from 0 to 5 mgml1)
(Sigma). The cells were incubated with digitonin for 5 min at
25 °C and centrifuged (2min, 18,000 g at 25 °C). The resulting
supernatants were gently transferred to new tubes, and the pel-
lets were resuspended in 1 ml of TSB and subjected to further
sonication. The enzymatic activities corresponding to pyruvate
kinase, hexokinase, citrate synthase (cytosolic, glycosomal, and
mitochondrial markers, respectively), and TcP5CDH were
measured in all of the supernatant and pellet fractions as
described elsewhere. All of the fractions were also subjected to
Western blot analysis using antibodies against TcTAT,
TcGAPDH, and TcProDH (cytosolic, glycosomal, and mito-
chondrial markers, respectively) as well as an antibody against
TcP5CDH.
Detection of TcP5CDH inMitochondrial Fractions—The iso-
lation ofmitochondrial vesicles fromT. cruzi epimastigoteswas
performed as described recently (57). The solubilization of
mitochondrial membrane proteins was performed in the pres-
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ence of 0.1%TritonX-100 (v/v) (5min at 4 °C), and clarification
was performed by centrifugation (16,000 g for 20min at 4 °C).
The supernatant was separated to confirm the presence of the
proteins by enzymatic activity measurements (total protein
mass, 100 g) and by Western blotting analysis (total protein
mass, 40g per lane). For the latter analysis, an additional total
cell-free extract from epimastigotes was used as a control (58).
Native Gel Electrophoresis (NGE)—Recombinant TcP5CDH
and mitochondrial fractions from T. cruzi epimastigotes were
resolved in NGE as described previously (59). Briefly, 4 g of
purified TcP5CDHwas mixed with 3NGE sample buffer (5%
Coomassie Blue G-250 (w/v) and 0.75 M aminocaproic acid)
and resolved in nondenaturing conditions followed by a com-
parisonwith themigration profile of theNativeMarkTMprotein
standard (Novex) or highmolecular weight nativemarker (GE
Healthcare). Mitochondrial fractions were prepared and solu-
bilized using either 10% DDM (w/v) dissolved in water or 10%
digitonin (DIG) (w/v) dissolved in a buffer containing 50 mM
NaCl, 50 mM imidazole, 5 mM aminocaproic acid, and 4 mM
PMSF. Detergent (in grams) ratios of 2:1 and 4:1 per g of total
protein content were used for DDM and digitonin treatments,
respectively. Thus, samples were incubated for 5 min on ice,
and the solubilized material was separated by centrifugation
(16,000  g for 20 min at 4 °C). The samples were mixed with
3 NGE sample buffer and loaded (50 g of mitochondrial
protein) onto native gels.
Protein Identification by Liquid Chromatography Coupled to
Tandem Mass Spectrometry—NGE slices containing the pro-
tein bands of interest were excised. After reduction with DTT
(10 mM) and alkylation of the Cys groups using iodoacetamide
(50 mM), modified porcine trypsin (Promega) was added at a
final mass ratio of 1:50 (trypsin/protein). The samples were
digested overnight at 37 °C, after which they were vacuum-
dried and dissolved in 1% acetic acid (v/v). To identify proteins,
the resulting tryptic peptide mixtures were analyzed by nano-
liquid chromatography coupled to mass spectrometry. The
peptides were injected into a C-18 reverse-phase nano-column
(100 m inner diameter and 15 cm; TK mediterraneaTM Sea,
Teknokroma) and analyzed on a continuous acetonitrile gradi-
ent consisting of 0–43% B for 90 min and 50–90% B for 1 min
(B  95% acetonitrile, 0.5% acetic acid). The peptides were
eluted from the reverse-phase nano-column at a flow rate of

300 nl/min into an emitter nanospray needle for real time
ionization and peptide fragmentation on an LTQ-Orbitrap
mass spectrometer (Thermo Fisher, San José, CA). An
enhanced FT-resolution spectrum (resolution 6000) and the
MS/MS spectra of the five most intense parent ions were ana-
lyzed during the chromatographic run (130 min). Dynamic
exclusion was set at 0.5 min. For protein identification, tandem
mass spectra were extracted, and the charge-states were decon-
voluted using Proteome Discoverer 1.2.0.207 (Thermo Fisher
Scientific). All of the MS/MS samples were analyzed by
SEQUESTTM (Thermo Fisher Scientific, version 1.0.43.2),
MASCOTTM (Matrixscience, version 2.1) and X! Tandem
(The GPM, version 2007.01.01.1). All searches were performed
assuming complete trypsin digestion. Two mixed cleavages
were allowed, and errors of 15 ppm or 0.8 Da were set for full
MS and MS/MS spectra searches, respectively. Oxidation on
Met, phosphorylation on Ser or Thr and deamidation onGln or
Asn were selected as dynamicmodifications. Identification was
performed by querying the Decoy database for FDR analysis.
Scaffold (version Scaffold_3_00_03, Proteome Software Inc.,
Portland, OR) was used to validate the identified MS/MS pep-
tides and proteins. Protein probabilities were assigned by the
Protein Prophet algorithm. Proteins that contained similar
peptides and that could not be differentiated based on MS/MS
analysis alone were grouped to satisfy the principles of
parsimony.
Expression Levels of TcP5CDH in the Parasite Developmental
Stages
Quantification of mRNA Levels—Total RNA was extracted
using the TRIzol reagent (Invitrogen) from all parasitic stages
and CHO-K1 cells (as a control). Each RNA preparation was
performed in triplicate according to the manufacturer’s proto-
cols. Yeast RNA preparations were performed according to a
standardized method (40). After extraction, the RNA samples
were treated with RNase-free DNase (Fermentas), which was
controlled under denaturing conditions and quantified spec-
trophotometrically following standard procedures (60). First
strand cDNA was synthesized from total RNA (5 g) using a
random primer set and the Superscript III reverse transcrip-
tase mix according to the manufacturer’s protocols (Invitro-
gen). Based on the T. cruzi nucleotide coding sequences
TcP5CDH and TcGAPDH as housekeeping gene GenBankTM
accession numbers are as follows: TcP5CDH, XM811985.1;
TcGAPDH, AI007393), specific primers for quantitative real
time PCR (qRT-PCR) analysis were designed. TcP5CDH for-
ward, 5-ATGCTTGGTGTGCACGAACA-3, and TcP5CDH
reverse, 5-CATCGATAACGGCGCACATA-3 (product size
76 bp), and TcGAPDH forward, 5-GTGGCAGCACCGGTA-
ACG-3, and TcGAPDH reverse, 5-CAGGTCTTTCTTTT-
GCGAAT-3 (product size 110 bp) were separately prepared in
a mixture containing 1.6 pmol of each primer for each corre-
sponding gene. qRT-PCR was performed in a Mastercycler ep
RealPlex (Eppendorf, Germany) using the SYBRGreen fluores-
cence quantification system (Fermentas, Life Sciences). The
PCR conditions were as follows: 95 °C (10 min) and then 40
cycles of 94 °C (1min), 57 °C (1min), and 72 °C (2min) followed
by a denaturation curve. The data obtainedwere analyzed using
RealPlex version 1.5 software. Fold changes in the expression of
each transcript were determined by applying the comparative
method (2Ct) using epimastigote stage data as a calibrator
(61). Differences among samples were analyzed with a one-way
analysis of variance followed by Tukey’s post test using
GraphPadPrismversion 5.00 software forWindows (GraphPad
software). The significance level (p value) was determined with
a confidence interval of 95% in a two-tail distribution.
Western Blot Analysis—Total protein extracts from the dif-
ferent stages of T. cruzi and CHO-K1 cells were prepared for
Western blot assays. The cells were harvested, washed twice
with PBS, and resuspended in 20l of extraction buffer (50mM
Tris-HCl, pH 7.4, 50 mM NaCl, 2 mM EGTA, 2 mM EDTA, 20%
glycerol (v/v), 1% Triton X-100 (v/v), 1mM PMSF, and protease
inhibitor mixture (Sigma). The cells were chilled on ice (30
min) and clarified by centrifugation (16,000  g for 15 min at
Proline Catabolism in Trypanosoma cruzi
MARCH 20, 2015•VOLUME 290•NUMBER 12 JOURNAL OF BIOLOGICAL CHEMISTRY 7771
4 °C). Supernatants corresponding to 2  107 T. cruzi cells or
5 106 CHO-K1 cells were mixed with 2 SDS-PAGE Laem-
mli buffer (44), boiled (5 min at 95 °C), and further subjected to
SDS-PAGE protein electrophoresis. Protein extracts from the
yeast cells were extracted as described previously (62) and used
in both enzymatic activity assays andWestern blotting analysis.
Then the proteins were electrotransferred (1.2mA cm2 of gel
during 75 min) onto 45-m Hybond-C extra nitrocellulose
membranes (Amersham Biosciences) and stained with 0.5%
Ponceau Red solution (p/v) dissolved in 10% acetic acid (v/v).
Polyclonal mouse antisera produced against TcP5CDH
(1:2000), TcGAPDH (1:2500), or TcASATm (1:3000) (46) were
diluted in PBS containing 0.1% Tween 20 (PBS-T) (v/v) and
used to probe for the blotted proteins (1 h at room tempera-
ture). The membranes were washed three times with PBS-T
and then incubated in the presence of horseradish peroxidase-
coupled goat anti-mouse IgG (Sigma) secondary antibody
(1:2500). Protein signals were developed using the Super-
SignalWest Pico chemiluminescent substrate (ThermoFisher
Scientific) following the manufacturer’s protocols.
Biochemical Characterization of TcP5CDH
Chemical Synthesis andAnalysis of P5C—P5Cwas synthesized via
themeta-peroxidation of DL-5-hydroxylysine (Sigma) and purified
by ion-exchange chromatography as described previously (63).
Eluted P5C was maintained in acidic medium (1 M HCl) and
quantified using a colorimetric method with o-aminobenzalde-
hyde (OAB) (16). Absorbance (443 nm) of the hydroquinone
complex (P5C-OAB) wasmeasured in 1-cm cuvettes using 0.25
M HCl as a reference instead of eluted samples. The molar
extinction coefficient (	) of the complex was 2,590 M1cm1
(16, 63). The intracellular P5C levels in the yeast cells were
determined according to a method described previously (32).
The purity and mass of synthetic P5C were analyzed by iso-
cratic HPLC and mass spectrometry, respectively.
Enzymatic Activity Determinations—The enzymatic activity
of TcP5CDHwas determined spectrophotometrically (443 nm)
bymonitoring the production of the reduced form of NADH as
the co-product of oxidized GS. Steady-state activities were
determined at 28 °C under saturating concentrations in a mix-
ture containing 100 mM HEPES-NaOH, pH 7.2, 0.6 mM syn-
thetic P5C (freshly prepared), 2mM of either NAD orNADP
(NAD(P)), brought to a volume of 3 ml with deionized water.
Enzymatic reactions were initiated upon the addition of either
10 g of recombinant TcP5CDH-His6 or 100 g of cell-free
total extract, depending on the assay. Measurements were per-
formed in 1-cm quartz cuvettes at 28 °C withmagnetic stirring.
Initial velocities were determined in the linear range of the time
course reaction using the 	 value for NADH (6200 M1cm1).
The kinetic data (Km and kcat) were determined for the three
substrates (L-GS and NAD(P)). Substrate parameters were
assayed by varying the P5C concentrations (10–1000 M) with
a fixed concentration of 2 mM NAD. Cofactor parameters
were separately assayed by varying the concentrations of each
NAD(P) (10–2500 M) with a fixed concentration of 0.3 mM
P5C. The effect of temperature on the specific activity of
TcP5CDH was assayed by raising the reaction temperature
within a range of 15–85 °C. The effect of pH variation on
TcP5CDH activity was assayed in 100 mM reaction buffer
adjusted to different pH values within a range of 5–9. To deter-
mine the activation energy at a steady state of TcP5CDH, the
Arrhenius equation was applied. Values were plotted, and the
resulting curves were adjusted to the Michaelis-Menten func-
tion using OriginPro version 8.0 software (OriginLab). Sub-
strate specificity was assessed separately in the presence of 0.4
mM distinct aldehydes structurally related to GS (succinate
semi-aldehyde, acetaldehyde, malonic acid, glutaric acid, and
glutamic acid). The activities of citrate synthase (EC number
4.1.3.7), hexokinase (2.7.1.1), and pyruvate kinase (2.7.1.40)
were measured using standard procedures. The activity of
fumarate reductase was measured as described previously (64).
Physiological Assays with P5C
Nutritional Starvation Assays—The ability of T. cruzi cells to
use P5C during nutritional starvation was evaluated. Briefly,
epimastigote forms (2 107 cells) were exposed to nutritional
depletion for 48 h at 28 °C in either PBS or PBS supplemented
with 1 mM of each substrate analyzed (D-glucose, L-proline,
L-glutamate, DL-P5C, and HCl as a control for the P5C treat-
ment). Next, cell viability was determined in the presence of
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) for 4 h (58, 65).
ATP Measurements—To determine whether the parasite
produces ATP from distinct sources after nutritional starva-
tion, an enzymatic light assay was used. Briefly, epimastigote
forms (5  106 cells) were starved by incubation for 24 h at
28 °C in PBS. During this period, intracellular ATP levels are
depleted without affecting cell viability, as confirmed by
microscopy. Next, the parasites were incubated (1 h at 28 °C)
with 1mMof the corresponding substrates to restore the energy
requirements, and the intracellular ATP contents were mea-
sured using a bioluminescence cell kit (Sigma) according to
the manufacturer’s protocols.
Infection Assay during P5C Supplementation—To evaluate
the effect of P5C on the intracellular cycle of T. cruzi, CHO-K1
cells (5 104 cells per well) were seeded into 24-well plates and
incubated for 24 h at 37 °C under a 5% CO2 atmosphere. Next,
the cells were washed with PBS, and 2  107 TCT forms were
added to each well in either RPMI 1640 media supplemented
with 10% FCS, PBS supplemented with 10% FCS, or PBS sup-
plemented with increasing concentrations of P5C (20, 50, and
100 M) to a final volume of 500 l and incubated for 3 h as
described above. After the incubation, the cells were washed
three times with PBS and fresh RPMI 1640 medium 2% plus
10% FCS. After an additional 24 h of incubation, the infections
were further incubated at 33 °C for 5 days. After this period, the
number of parasites released into the culture media was deter-
mined by counting using a hemocytometer.
RESULTS
Identification and in SilicoAnalysis of TcP5CDH—A1686-bp
open reading frame encoding a putative 62.4-kDa TcP5CDH
was found in the genome database. This sequence is henceforth
referred to as TcP5CDH1. Two additional sequences were also
found. TcP5CDH2 (Tc00.1047053509351.10) exhibits 98%
amino acid sequence identity with the N-terminal portion
Proline Catabolism in Trypanosoma cruzi
7772 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 290•NUMBER 12•MARCH 20, 2015
of TcP5CDH1, whereas TcP5CDH3 (Tc00.1047053503577.9)
shares a 73% amino acid sequence identity with the C terminus
of TcP5CDH1. TcP5CDH1 was sequenced (EBA database
access code numberHG326611) and further used for functional
characterization experiments as described in this work.
Analysis of the TcP5CDH1 amino acid sequence revealed
high sequence identity with other hemoflagellate putative
orthologs, such as T. brucei (82%) and L. major (68%), followed
by orthologs from eukaryote organisms such as S. cerevisiae
PUT2 protein (48%), Drosophila melanogaster P5CDh1 (45%),
H. sapiensALDH4A1 (42%), the E. coli putA domain (29%), and
T. thermophilus TtP5CDH (32%) from bacteria and archaea
(Fig. 1A). A query of the InterProscan database revealed the
presence of conserved domains that characterize proteins
belonging to the aldehyde dehydrogenases family,NAD-bind-
ing (Glu302, Phe387, and Leu441) and glutamate-binding (Cys336
and Ser340) enzymes, in which the specific residues are likely to
be involved in catalytic processes, as reported previously in
archaea and human orthologs (Fig. 1A) (25, 66).
Currently, all reported eukaryotic forms of P5CDH aremito-
chondrial enzymes. An attempt to identify mitochondrial tar-
geting sequences by means of available bioinformatics
resources (SignalP,MitoProt, andTargetP) did not reliably sup-
port thepresenceof this targeting sequence.However, visual anal-
FIGURE 1. In silico analysis of the deduced amino acid sequence for TcP5CDH. A, alignment of primary sequences for P5CDHs from different species. The
aligned sequences correspond to orthologous proteins from H. sapiens (ALDH4A1), D. melanogaster (P5CDh1), T. cruzi (TcP5CDH), T. brucei (TbP5CDH), L. major
(LmP5CDH), S. cerevisiae (PUT2), E. coli (putA), and T. thermophilus (TtP5CDH). Accession code numbers are detailed under “Experimental Procedures.” The
alignment was performed using the ClustalW method (default parameters) (41). Protein signatures found in the mTP (Met1–Ser18) indicating the MLRR (†††)
and alanine-rich FAFAYA (¥¥¥) domains and the putative cleavable site (arrow) of TcP5CDH. The predicted trans-membrane region (Phe200–Trp221) is highly
conserved among trypanosomatid sequences (- - -), as are the conserved catalytic residuesGlu302, Phe387, Leu441 (stars), andCys336, Ser340 (circles), as shownby
previous structural data. B, -helical structure presented inmTP region using the heliQuest software. The resultingmodel depicts the positive () (Arg3, Arg4,
and Lys16) and hydrophobic (H) (Leu2, Leu6, Ala9, Ala11, and Ala13) residues and the putative Thr17 (arrow) cleavable site. C, bioinformatic analysis for the
transmembrane region found for TcP5CDH. The complete amino acid sequence for TcP5CDH (561 residues) was used as the input sequence for the Phobius
predictor tool. The graphic layout shows the probability values (0–1) for the transmembrane (TM) domains in gray, cytoplasmic (C) in green, noncytoplasmic
(NC) in blue and signal peptide (SP) in red.
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ysis of the N-terminal portion (Met1–Val20) revealed protein fin-
gerprints common in mitochondrial targeting sequences from
kinetoplastid organisms (67). The presence of three positively
charged residues (Arg3, Arg4, and Lys16), a conserved-motif
MLRR, an alanine-repeat track (FAFAYA), and a putative -helix
suggested a mitochondrial location (Fig. 1, A and B). In addition,
we identified a hydrophobic region (Phe198-Gly215) with charac-
teristics of a putative transmembrane -helix spanning domain
(Fig. 1C).
TcP5CDH Can Complement the Activity of a PUT-deficient
Yeast Strain (PUT2)—To confirm that TcP5CDH encodes a
protein with P5CDH activity, a PUT2 yeast mutant strain
lacking P5CDH activity, which is unable to use proline as the
single nitrogen source, was used for functional complementa-
tion. As the designated yeast strain exhibited intrinsic auxotro-
phy for histidine and leucine, it was initially modified to be able
to synthesize these metabolites by the insertion of the genes
HIS3 and LEU2 (Table 1). These modifications allowed for the
use of a selectivemediumwithout these amino acids, whichwas
crucial for the assay, as an excess of these amino acids might
facilitate their use as alternative nitrogen sources in S. cerevisiae
(68). Thus, yeasts that are able to grow in selective media con-
taining only a carbon, nitrogen, and a sulfur source were
obtained. TcP5CDH1was cloned into the pYES vector, and the
construct was inserted into the modified yeast PUT2. Pheno-
typic analysis of the transformed cells in definedmedia revealed
that proline was a suitable nitrogen source, as was ammonium
sulfate (used as control), for both the wild-type (S288c) and the
complemented TcP5CDH strain (Fig. 2A). In addition, the sen-
sitivity of S288c to G418, the plasmid selection marker, was
verified. Furthermore, the presence of the transcript for
TcP5CDH was detected only in the TcP5CDH-transformed
clones (Fig. 2B), andTcP5CDH (which shares 44% identity with
S. cerevisiae orthologs) (Fig. 1A) was detected with an anti-
TcP5CDH serum, indicating the presence of the T. cruzi pro-
tein in the TcP5CDH-transformed clones (Fig. 2C). Finally,
both the intracellular P5C content and functional activity of
TcP5CDH was assessed. The specific activity of P5CDH in the
TcP5CDH complemented strain was compatible with that
obtained for the wild-type cells (Fig. 2D). This result was con-
FIGURE 2. Yeast functional complementation assay. PUT2 activity-deficient mutant strain was transformed by the episomal insertion of the TcP5CDH gene.
A, drop tests in selectivemedia. For phenotypic analysis, yeast cells were grown in liquidmedium (until A600 nm 1) and then serially diluted (1–10
5) in sterile
water prior to spotting. Synthetic complete plates (SC) contained a dropout mix with all amino acids, including uracil, ammonium sulfate, and galactose as
nitrogen and carbon sources (SC1). SC without uracil or ammonium sulfate but with proline and G418 added are referred to as SC2. Synthetic depleted plates
(SD) containedonlymethionine, ammoniumsulfate, andgalactose (SD1) ormethionine, proline, andgalactose (SD2). Final concentrations are describedunder
“Experimental Procedures.” Cells were incubated at 28 °C for 2 or 4 days for the SC and SD tests, respectively. B, transcriptional levels of TcP5CDHwere assayed
by RT-PCRwith specific primers. Amplified products were resolved in 1% agarose gel (w/v) and stainedwith 0.5gml1 ethidium bromide. Gel samples were
loadedas follows: 1st lane,1-kbDNA ladder (Fermentas); 2nd lane,products amplifiedusing either total genomicDNA fromepimastigote forms; 3rd lane, total
cDNA fromwild-type yeast; 4th lane, cDNA from thePUT2mutant; or 5th lane, cDNA from the TcP5CDHmutant as templates in PCR. C,Western blot analysis
with protein extracts was performed as indicated. Membranes were probed against anti-TcP5CDH produced in mice (1:2000) and developed as described
elsewhere.D,biochemical analysis of yeast cells. Cell-free extracts (100g) from500mlof yeast cells, grown ineither SC1or SC2media,wereusedas anenzyme
source in enzymatic determinations (left axis) or reacted with OAB for the quantification of free P5C levels. Intracellular P5C levels are expressed as the
concentration (M) ratio with respect to the biomass of dried yeast cells (grams) (right axis). The data are representative of three independentmeasurements.
TABLE 1
List summarizing the yeast strains used in this study
The abbreviations used are as follows:PUT2, knockout strain for the proline utilization 2 gene (PUT2); control, control strain; TcP5CDH, complemented strain harboring
cds for P5CDH in T. cruzi. TheWT strain lacks auxotrophy, whereas the PUT2 strain exhibits auxotrophy for HIS,MET, LEU, and URA and is also deficient in P5CDH
activity. Both control and TcP5CDH strains exhibit auxotrophy only forMET, whereas the control strain is unable to grow when proline is the only nitrogen source.
Strain Name Plasmids inserted Resultant genotype
S288c WT None MAT; SUC2; GAL2;MAL;MEL; FLO1; FLO8-1; HAP1; HO; BIO1; BIO6
BY4741 PUT2 None MATa; HIS31; LEU20;MET150; URA30; YHR037w::KANMX4
Control pYEp351, pYES-HIS3 MATa;MET150; YHR037w::KANMX4
TcP5CDH pYEp351, pYES-HIS3, pYES-TcP5CDH MATa;MET150; YHR037w::KANMX4; TcP5CDH
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sistent with the similar levels of intracellular pools of free P5C.
As expected, this activity was evidenced by the accumulation of
P5C in both PUT2 and control cells (Fig. 2D). These data
demonstrate that the protein product ofTcP5CDH functionally
reverts the phenotype of the PUT2 mutant in terms of both
the increased levels of the intermediate P5C and its inability to
metabolize proline as a single nitrogen source in a defined
medium, indicating its P5CDH enzymatic activity.
Expression, Purification, and Determination of the Oligo-
meric State of TcP5CDH—To confirm the functionality of the
TcP5CDH protein product, its DNA sequence was cloned and
expressed in E. coli as a protein fused with a six histidine tag in
the C-terminal region. The TcP5CDH-His6 was purified by
affinity chromatography using a Ni2-nitriloacetic resin fol-
lowed by size-exclusion chromatography (SEC) and enzymati-
cally active in the presence of detergent (DDM). In addition, a
recombinant TcP5CDH product, lacking the N-terminal tar-
geting pre-sequence (first 22 residues), showedno alterations in
the enzymatic rates (data not shown).
The chromatogram (280 nm) obtained from the SEC of
recombinant TcP5CDH-His6 exhibited two major peaks (P1
and P2) with different elution times, suggesting different oligo-
merization states (Fig. 3A and Table 2). These fractions were
also resolved by SDS-PAGE, which revealed a single protein of
the expected size (64 kDa) only in the P2 samples (Fig. 3A).
The estimation of molecular size for P1 using SEC, along with
the fact that SDS-PAGE did not resolve the proteins in the
samples, suggested that the protein recovered in P1 was aggre-
gated. Consistently, P1 did not show enzymatic activity,
whereas P2 presented a P5CDH activity (Table 2). Next, to con-
firm that P1 consisted of aggregated protein and to determine
the oligomeric state of active TcP5CDH, we analyzed the data
from SEC, DLS, and SAXS measurements and NGE. SEC mea-
surements, DLS, and NGE for P2 revealed a high molecular
FIGURE 3.Analysis of purified TcP5CDH-His6 in solution.A, recombinant TcP5CDH-His6was produced in E. coli andpurified by affinity chromatography and
SEC. After SEC separation, two major peaks (280 nm) were observed (P1 and P2), and the protein sample was subjected to electrophoresis in a 10% SDS-
polyacrylamide gel stainedwith Coomassie Blue (right inset). Size determinations were determined from calibration curve used in SEC separation (left inset). B,
BNGE of the pooled fractions from SEC. Fractions 44–47 (corresponding to P1) and 51–54 (corresponding to P2) were pooled, concentrated, and resuspended
at 0.5g/l in P5CDHbuffer in the presence or absence of 0.02%DDM.Molecularmass determinationswere determinedby comparing the samplesmigration
against protein standards.C,DLSof P2wasperformedat threedifferent concentrations. Fractions 51–54 (corresponding toP2)werepooled, concentrated, and
resuspendedat 0.3, 0.75, and1.5g/l in P5CDHbuffer in thepresenceof 0.02%DDM.Hydrodynamic radius (RH) andmolecularmass (MW)were similar for the
tested concentrations.D, distance distribution function of TcP5CDH from the experimental x-ray scattering data. The determined value ofmaximumdistance
(Dmax) is indicated. E, experimental solution scattering curves of TcP5CDH-His6 (log I versus q) and the results of the fitting procedures. Fraction P2 was
resuspended in buffer containing 90mMHEPES-NaOH, pH 7.2, and 5%glycerol (v/v) andwas concentrated up to 2.5mgml1. Scattering curves obtained from
experimental data for TcP5CDH from thehigh resolutionmodel (ProteinDataBank code1UZB) and scatteringpatterns computed from theGasbormodelwere
plotted as indicated. The inset displays the correspondent Guinier plot (log I versus q2). F, low resolution structure of the TcP5CDH in solution as obtained by
Gasbor (spheres)with superpositionof thehigh resolutionmodel (1UZB) (ribbons). Themodelswere rotated90°with respect to the yaxis.a.u., absorbanceunits.
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mass oligomer of 715, 649, and700 kDa, respectively (Fig. 3A
and Table 2). The molecular size of TcP5CDH within the P2
fraction is consistent with the DLS data, collected at different
concentrations. In addition, the DLS profile showed that the
homogeneous (not aggregated) state of TcP5CDH is consistent
at different concentrations (tested: 0.3, 0.75, and 1.5 mg/ml).
Taken together, these data suggest that TcP5CDH adopts an
oligomeric conformation with 10 to 12 subunits. Next, SAXS
experiments with the TcP5CDH apoenzyme in solution (from
P2) were performed to confirm the absence of aggregates and
the oligomeric state of the enzyme in this fraction. The linear
region observed at the beginning of the curve (values of q
between 0.015 and 0.048 Å1 or q2 between 0.00025 and
0.00225 Å as expressed in Fig. 3D, andD, inset) was considered
to obtain Rg values by using the method of Guinier. The linear-
ity of the curve in this range showed that the protein solution
was homogeneous,meaning that no aggregateswere evidenced.
To estimate the size of the complex (number of subunits) as
well as its molecular weight, the obtained curve was compared
with a theoretical one generated for a crystallized hexameric
P5CDH as described under “Experimental Procedures.” As can
be seen, the theoretical curve obtained from a hexameric crys-
tallographic structure of P5CDH overlapped the experimental
curve obtained with TcP5CDH (P2 fraction) (Fig. 3D). This
behavior strongly supported that TcP5CDH is present predom-
inantly as a 364.6-kDa hexamer at a concentration of 2.5 mg
ml1. The typical scattering curve and distance distribution
function p(r) obtained with TcP5CDH at 2.5 mg ml1 are pre-
sented in Fig. 3,D and E, respectively. All model curves yielded
optimal fits with the experimental data. The experimental val-
ues of Dmax and Rg, 200 and 65.21  0.53 Å, respectively, sug-
gest that TcP5CDH is approximately in a globular configura-
tion (Fig. 3F).
Enzymatic Conversion of DL-P5C in Glutamate—The bio-
chemical characterization of TcP5CDH involves the synthesis
of DL-P5C, which is not commercially available. DL-P5C was
prepared by oxidizing DL-5-hydroxylysine with periodate in
acidic media (63). The concentration of DL-P5C was deter-
mined using the OAB colorimetric assay (Fig. 4A). MS analysis
(Fig. 4B) indicated the presence of DL-P5C (m/z 114), the cor-
responding hydrolyzed ring-opened form (GS, m/z 132), and
the chlorinated derivative (m/z 162). After a purification step,
the produced DL-P5C was immediately used to investigate the
enzymatic activity of both native and recombinant TcP5CDH
(Fig. 4C). Although quantum chemical calculations indicate
that the equilibrium in water is greatly shifted to P5C rather
than to GS (G0  41 kJ mol1, K  2.2  107; Fig. 4D),
crystallographic evidence suggests that GS is the substrate of
TcP5CDH (Inagaki et al. (25)). Therefore, the product of perio-
date oxidation of L-proline will be referred to as P5C through-
out the text, whereas GS will be assumed to be enzymatically
converted into L-glutamate (see under “Discussion”).
The effects of the reaction conditions were investigated. The
Km value for the oxidation of GS to L-Glu in the presence of
TcP5CDH-His6 and saturating NADwas found to be 72 21
mol liter1. When mitochondrial lysates were used as a cell-
free source of the enzyme, a Km of 43  0.5 mol liter1 was
observed (Table 3). Both recombinant and mitochondrial
lysate-derived enzymes exhibited increased affinities for GS in
the presence of the cofactor NAD (Km  72.3 mol liter1)
comparedwithNADP (Km 342mol liter1) (Table 3). The
enzymatic conversion was pH-dependent, and an optimal pH
of 7.2 for either mitochondrial lysates or recombinant
TcP5CDH-His6 was determined (Fig. 5A). AlthoughTcP5CDH
is inactivated at temperatures above 45 °C, activation parame-
ters were determined within a temperature range between 20
and 45 °C (Fig. 5B). The resulting curvedArrhenius plot depicts
two distinct barriers, one exhibiting a lower value of 5.8 kJ
mol1 and the other with a higher value of 32.2 kJmol1 (Fig.
5B). Finally, as P5CDHs are aldehyde dehydrogenases, alde-
hydes other than GSmight serve as substrates. Thus, we eval-
uated the specificity of TcP5CDH. We observed that the
enzyme showed negligible specific activity in the presence of
other structurally related metabolites such as succinate semial-
dehyde, acetaldehyde, malonate, glutarate, and adipic acid.
Based on genomic and experimental data, a biochemical
scheme of the proline-glutamate interconversion pathway is
represented for T. cruzi (Fig. 6).
TcP5CDH Activity Is Associated with Mitochondrial Mem-
branes—Kinetic data showed thatTcP5CDHwas enzymatically
active in the presence of either NAD or NADP, and no
remarkable differences were observedwhen saturating concen-
trations of each cofactor were tested (Fig. 7A). Because mito-
chondrial membranes are not permeable to these cofactors, we
assayed the activity of TcP5CDH using both solubilized and
intact mitochondrial preparations from epimastigote forms.
The values obtained revealed a basal activity of 4.7 0.5 mol
min1 mg of protein1 for TcP5CDH in intact mitochondria
(Fig. 7B). This activity increased 5-fold upon the addition of
Triton X-100 to the preparations (21  2 mol min1 mg of
protein1) (Fig. 7B) and decreased when NADPwas used as a
cofactor (11  1.2 mol min1 mg of protein1), confirming
that TcP5CDH activity can be dependent on either cofactor.
To determine the mitochondrial compartment in which
TcP5CDH is located, the previously obtained data were com-
pared with specific activities for citrate synthase (CS) (mito-
chondrial matrix enzyme) and fumarate reductase (mitochon-
drial inner membrane enzyme). Because the mitochondrial
matrix content from vesicles is released during extraction,
likely during a re-sealing process (10), no CS activity was
detected in the mitochondrial vesicles. However, a higher spe-
TABLE 2
Comparative analysis of the molecular mass for TcP5CDH
Recombinant TcP5CDH dissolved in fraction P2 (Fig. 3A) was subjected to gel
filtration (GF), which facilitated the determination of the Stokes radius and the
molecular mass from the resulting equation (Fig. 3, inset). P2 fraction was used to
compare the molecular mass of TcP5CDH by either DLS or SAXS measurements.
Native gel analysis of P2 revealed an estimation of the molecular mass based on its
electrophoretic mobility, whereas the Stokes radius could not be detected (ND).
Technique Stokes radius Molecular mass
Å kDa
GF 81.1 714.9
DLS 97.1a 649.3
SAXS 65.21b 364.6
BNGE ND 480/720
a DLS assays revealed a Stokes radius with a mono-dispersal peak.
b The SAXS measurements of TcP5CDH in solution resulted in a gyration radius
of 65.21 0.53 Å and a maximal diameter of 200 Å based on a distance distribu-
tion function calculated using Fit2D and SAXS MoW software (53).
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cific activity for fumarate reductase was observed, suggesting
that the preparations were enriched with mitochondrial mem-
brane content (data not shown). The enzymatic activities
detected in the mitochondrial fractions were also confirmed
by Western blot analysis. The mitochondrial isoform of
TcASATm was previously reported as a mitochondrial matrix
protein (46). Thus, the polyclonal serum anti-TcASATm
(expected size 45 kDa) was reactive in T. cruzi total extracts
(Te), whereas in mitochondrial (Mc) preparations, the signal
was not apparent (Fig. 7C). Conversely, TcP5CDHwas detected
in both Mc and Te preparations (Fig. 7C), with the Mc prepa-
ration exhibiting a slight difference in its band migration com-
pared with the Te preparation (Fig. 7C). Taken together, our
biochemical data indicate that TcP5CDH activity occurs in
association with mitochondrial membranes in T. cruzi.
TcP5CDH Oligomer Is Bound to Mitochondrial Membranes—
As noted above, an N-terminal region with characteristics of a
mitochondrial targeting pre-sequence (Fig. 1, A and B) and a
putative trans-membrane spanner were found in TcP5CDH
(Fig. 1C). The above-described biochemical data obtained from
FIGURE 4.Analytical test of chemically synthesized P5C. A,wavelength scans of synthesized P5C. TheDHQ yellow-colored complex absorbs light within the
visible light range (443 nm), enabling its quantification as 	 2590 M
1cm1. B,mass spectrum of synthetic P5C. After synthesis, the product was dissolved in
two distinct solutions (pH 4.5 and 7.0) using a mixture of H3PO4/K
 phosphate buffer. Next, the sample was dissolved (1:2) in formic acid 1% (v/v) and further
injected in a Finnigan Surveyor Mass Spectrometer Quadrupole Plus-MSQ (Thermo Fisher Scientific). Chromatograms from each injection were recorded and
merged to analyze the differences among peaks of interest. Peaks corresponding to P5C, GS, and Cl-GS were detected, as indicated. A single peak with a
mass-to-charge ratio of 114.15m/zwas detected for P5C. C,wavelength scans for reactants involved in the enzymatic assay for TcP5CDH. The reaction assay
was prepared as described under “Experimental Procedures,” and the reaction was initiated with 200g of T. cruzi total lysates. Next, wavelength scans were
performed (260nmmin1), and theUV-visible light spectrawere recordedover the reaction time. Thegraph indicates the threemainpeaks for P5C/GS,NAD,
and NADH obtained at 220, 280, and 340 nm, respectively. D, structural representation of the spontaneous conversion between ring (P5C) and opened (GS)
forms in aqueousmedium. Optimized structures of SMD-B3LYP/6–311G (d,p) and values for the free-cyclization energy and the equilibrium constant (Keq)
are depicted. Lowest unoccupied energy molecular orbital (LUMO) depicts the sites for potential interaction with nucleophilic species.
TABLE 3
Kinetic parameters for the natural substrate (GS) and cofactors estimated in both the recombinant form (TcP5CDH-His6) (left) andmitochon-
drial vesicles from T. cruzi (right)
Measurements were performed on saturated concentrations of NAD (2 mM) for GS determinations and GS-saturated (1 mM) NAD(P) determinations as described
previously. To determine kcat values, 10 g of recombinant TcP5CDH or 100 g of mitochondrial proteins were used in a 3-ml reaction volume. Enzymatic activities were
initiated upon the addition of the enzyme, and changes in absorbance were measured over 5 or 15 min for recombinant TcP5CDH or mitochondrial extracts, respectively
(at 28 °C with constant stirring).
Substrate
Mitochondrial lysate TcP5CDH-His6
Km kcat kcat/Km Km kcat kcat/Km
M s1 M1 s1 M s1 M1 s1
GS 43 0.5 130.7 10 3 0.1 72 21 7 0.5 0.097 0.011
NAD 39 3,8 89.2 1.6 2.3 0.26 72.3 14.1 7.5 0.4 0.103 0.028
NADP 302 66 116.8 7.1 0.39 0.1 342 140 1.2 0.14 0.003 0.001
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mitochondrion-derived vesicles support the functionality of
both the mitochondrial targeting and the membrane-spanning
sequences. Considering that our mitochondrial vesicle prepa-
rations resulted in enzymatically active proteins and that
TcP5CDH is a membrane-bound protein, we addressed
whether the quaternary structure of its oligomermight be pres-
ent in T. cruzimitochondria.
To address this question, we analyzed recombinant
TcP5CDH by BNGE followed by Western blot analysis. A pre-
dominant band with an apparent molecular mass of 720 kDa
and a weaker band of 
440 kDa was detected (Fig. 8A). Mito-
chondrial proteins in BNGE exhibit distinct migration profiles
depending on the type of detergent used (Fig. 8B). When those
samples were solubilized with digitonin, electrophoresed in
BNGE, transferred, and probed with anti-TcP5CDH, a single
reactive band with an apparent molecular mass of 400 kDa was
detected (Fig. 8B). These data are consistent with the SAXS
estimations of TcP5CDH, further supporting the hexameric
conformation of this protein.
To verify themolecularmass of native TcP5CDH,mitochon-
drial membrane fractions were analyzed by BNGE, and the
bands migrating within the regions corresponding to those of
recombinant TcP5CDH were sampled for MS analysis. As
expected, those samples were predominantly enriched in sub-
units of mitochondrial respiratory complexes such as complex
II (succinate dehydrogenase) and complex IV (cytochrome c
oxidase) of T. cruzi, as evidenced by in-gel activity assays (data
not shown) andMS data (Table 4). Mitochondrial protein sam-
ples were solubilized either by using digitonin or DDM and
further resolved by BNGE (Fig. 8C). The analyzed bands (num-
bered 1–5) revealed the presence of different subunits for com-
plex II (bands 3 and 5) and complex IV (bands 1, 4 and 5), with
molecular sizes ranging between 550–600 and 350–400 kDa,
respectively (Table 4). TcP5CDHwas detected in all of the pro-
tein samples (1–5; Fig. 8B), with up to 17 peptides and 25%
coverage (Table 4). The differences in the migration profiles in
which TcP5CDH was detected revealed two types of associa-
tions between the oligomeric forms of TcP5CDH and themito-
chondrial membranes, exhibiting molecular masses of 
600
and 350–400 kDa.This range is similar towhat can be observed
for certain respiratory complexes from T. cruzi (Table 4).
To confirm whether the anti-TcP5CDH signal from mito-
chondrial protein resolved in BNGE corresponds to TcP5CDH,
we performed a second-dimensional run under SDS-PAGE
conditions, blotted the protein into a membrane, and probed it
with the same antibody. Interestingly, digitonin treatment of
FIGURE 5. Effect of pH and temperature variations on the TcP5CDH activity. A, pH of themedia in the reaction catalyzed by TcP5CDHwasmodified using
different buffer systems. Enzymatic activitywas determined in the presence of 2mMNADdisodium salt, 0.3mMGS, and 100mMof reaction buffer as follows:
MES-NaOH (pH 5, 6) (filled circles), MOPS-NaOH (pH 6.5, 7) (open squares), HEPES-NaOH, pH 7.2, 7.6 (open triangles), potassium phosphate, pH 7.2, 7.6 (inverted
triangles), Tris-HCl, pH 8, 8.5 (diamonds), and CHES (9, 9.5) (filled squares). The reaction was initiated by the addition of the enzyme, and initial velocities were
calculated as linear rates at 5 or 15min (at 30 °C with constant stirring) for the TcP5CDH-His6 or total lysates, respectively. B, effect of temperature variation in
reactions catalyzed by TcP5CDH. Enzymatic activity was determined by progressively increasing the reaction temperature (from 20 to 75 °C). Arrhenius plot of
the specific activity of TcP5CDH and the temperatures were assayed. y axis, log of Vmax according to temperature values used; x axis, temperature values
1
(Kelvindegrees) tested. The resultingplotwas adjusted toa linear function todetermine theenergyof activationderived fromthe respectiveequation (slope
Ea) (CI 95%).
FIGURE 6. Biochemical steps involving P5C/GS intermediates. The proline-
glutamate interconversion pathway in T. cruzi involves two enzymatic steps in
either the catabolic or biosynthetic pathway. L-Proline is oxidized to P5C by the
FAD-dependent proline dehydrogenase (TcPRODH) (1.5.99.8) (UniProtKB code
number F2WVH3). The reduction of P5C in proline is mediated by the enzyme
P5C-reductase (TcP5CDR) (EC 1.5.1.2) (K4EAX2) and is coupled to NADPH oxida-
tion. The reduction of glutamic acid into P5C requires two steps as follows. (i)
Glutamic acid is first activatedby anATP-dependent kinase toproduceglutamyl
1-phosphate, which is in turn converted to GS by the NADPH-dependent P5C
synthetase (TcP5CS) (EC 2.7.2.11) (K4E0F1). GS is the equilibrium formof P5C in
aqueousmedium. (ii) carbonylmoiety ofGS is further oxidized toglutamic acid
concomitantlywith reductionofNAD(P)HbyP5C-dehydrogenase (EC1.5.1.1) (4)
(Q4DRT8), which is the enzyme investigated in this study.
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the mitochondrial fractions released two anti-TcP5CDH-reac-
tive proteins with distinctmolecular weights, as observed in the
first-dimensional run (Fig. 8C). The higher molecular mass
band was more reactive than the lower one; both bands exhib-
ited amolecularweight thatwas equivalent to that of themono-
meric form of TcP5CDH (63 kDa). The higher band showed
more reactivity to anti-TcP5CDH, and a slight difference in its
migration profile under the second dimension was also
observed (Fig. 8C, left side). In contrast, treatment with dodecyl
maltoside, a detergent that preserves intact individual mito-
chondrial complexes, released a single protein of the same
molecularmass (Fig. 8C, right side). These results are consistent
with our previous observations by SAXS measurements and
enzymatic assays in mitochondrial vesicles, supporting a qua-
ternary conformation for TcP5CDH that is characteristic of a
homohexamer. Nevertheless, the assumption that TcP5CDH
might interact with other mitochondrion-forming supra-mo-
lecular complexes and components in T. cruzi cannot be
excluded.
Subcellular Localization of TcP5CDH IsConserved in theDis-
tinct Parasite Stages—The co-localization profile of TcP5CDH
with mitochondrial probes in distinct developmental forms of
the parasite was used to evaluate its mitochondrial localization.
TcP5CDH staining inside mammalian iCHO cells is isoform-
specific for T. cruzi and correlates with intracellular parasitic
load (Fig. 9A,merged panel). Detection of TcP5CDHwith poly-
clonal serum shows a labeling pattern comparable with that
found using the MitoTracker probe. In addition, marked
staining was observed in a central region that co-localizes with
the region highlighted by kDNA staining (Fig. 9A, merged
panel). The co-localization of TcP5CDH with the Mito-
Tracker probe suggests the presence of the proteinwithin par-
asite mitochondria.
Sequential digitonin permeabilization in epimastigote forms
was also employed to confirm themitochondrial localization of
TcP5CDH. This permeabilization technique allows for the
gradual release of the cellular contents from different compart-
ments, such as the cytosol, glycosomes, reservosomes, and
FIGURE 7. Cofactor dependence and membrane-bound activity of TcP5CDH. A, evaluation of cofactor specificity for TcP5CDH. Specific activity was
individually determined in the presence of GS (0.3 mM) and either NAD or NADP (2 mM). Analysis of TcP5CDH present in mitochondrial vesicles of T. cruzi.
B, enzymatic activity was measured in mitochondrial preparations from replicative E forms that were solubilized () or not () with detergent (Triton X-100).
The composition of the reaction mixture was detailed previously, and each reaction was initiated upon the addition of mitochondrial extract as an enzyme
source. When Triton X-100 was added, the activity of TcP5CDH significantly increased. When NADPwas used as a cofactor, a similar increase was observed.
All of the measurements were conducted by monitoring the change in absorbance (340 nm) at a linear rate (30 °C by 15 min under constant agitation). C,
Western blot analysis of TcP5CDH in mitochondrial (Mito) vesicles. Polyclonal serum (diluted 1:3000 in PBS-T plus skim milk 0.3% w/v) against the TcASATm,
used asmitochondrialmarker, was probed against bothmitochondrial and total extracts (Te) fromE forms. Similarly, anti-TcP5CDH (1:2000)was used to probe
both mitochondria and total extracts. The assay detected TcP5CDH in protein extracts from both total extracts and Mc.
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mitochondria, upon treatment with increasing concentrations
of digitonin. Samples were evaluated for TcP5CDH and mark-
ers by both Western blotting and biochemical activity assays.
Western blot analysis showed that TcTAT, a cytosolic marker
(48), was released at digitonin concentrations ranging from 0.1
to 5 mg ml1 (Fig. 9B), whereas TcGAPDH, a glycosomal
marker, was released at intermediate digitonin concentrations
(0.5–3mgml1). Finally, TcProDH, amarker corresponding to
the mitochondrial content, was released at higher digitonin
concentrations (1.5–5 mg ml1) (Fig. 9B). TcP5CDH was
detected at intermediate digitonin concentrations (1.5–2.5 mg
ml1), which were compatible with either glycosomal or mito-
chondrial content (Fig. 9B). To confirm this result, the same
samples were used to detect TcP5CDH and subcellular com-
partmentmarkers bymeasuring biochemical activities. For this
purpose, enzymatic activities for PK (cytosolic), hexokinase
(glycosomal), and CS (mitochondrial marker) were also used
(Fig. 9C). Thus, the percentage of TcP5CDH activity was pre-
dominantly detected at concentrations of 1–5 mg ml1 of dig-
itonin. This range was higher than that presented in the West-
FIGURE 8. TcP5CDHnative gel electrophoretic analysis.A, recombinant TcP5CDH-His6 (fraction P2, Fig. 3A) was resolved byNGE using a 4–16%acrylamide/
bisacrylamide gradient gel. Lane 1,molecular mass marker for nondenaturing gels (GE Healthcare); lane 2, recombinant TcP5CDH-His6 (4g). The gel was run
at 4 °C and further stainedwith Coomassie Blue R-250 solution as described under “Experimental Procedures.” Right panel,Western blot analysis from theNGE
sample usingpurified anti-TcP5CDH (1:500).B, analysis of the TcP5CDHpresent in themitochondrial fractions under native conditions. Sampleswereprepared
from epimastigote forms, and the mitochondrial content (MitoC) was solubilized with either DIG or DDM. The mitochondrial fractions were first resolved by
BNGE. Both of the samples (DIG and DDM) were electrotransferred to nitrocellulosemembranes and probed with polyclonal anti-TcP5CDH; only DIG samples
exhibited immunoreactivity. A single band of highmolecular mass (450 kDa), presumably mitochondrial membrane-bound, was detected (note: the bands
marked 1–5 correspond to the gel areas selected for proteomic analysis byMS/MS as summarized in Table 3). C, two-dimensional (2-D) analysis was performed
under denaturing conditions (SDS-PAGE 12%). Samples from the first dimension (1D) native gel were excised (dotted region) and embedded in a gel cast for
separation using conventional protein SDS-electrophoresis. After electrophoresis (two-dimensional), the proteins were electrotransferred to nitrocellulose
membranes and probedwith polyclonal anti-TcP5CDH. The boxes indicate proteins that were distinguished under solubilization conditions, showing two and
one reactive bands for the DIG and DDM treatments, respectively. In both cases, the proteins exhibited a molecular mass compatible with that expected for
TcP5CDH (
63 kDa).
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ern blot analysis. The release of TcP5CDHwas slightly different
from that of CS (Fig. 9C), which was observed at digitonin con-
centrations above 2.5 mg ml1. Glycosomal content was
released at intermediate digitonin concentrations (1.5–2.5 mg
ml1), similar to what was observed for hexokinase percentages
(Fig. 9C). Hence, the data suggest that CS release requires higher
digitonin concentrations compared with that required for
TcP5CDHrelease.This result is consistentwitheither theouteror
inner mitochondrial membrane localization of TcP5CDH.
TcP5CDH Is Up-regulated in the Infective Stages of the
Parasite—TcP5CDH expression levels were analyzed in all of
the developmental stages of T. cruzi. The mRNA levels were
quantified in relative terms using the epimastigote stage as a
reference (fold change  1). Both M and TCT-infected stages
exhibited increased mRNA levels (Fig. 10A) (p value 	 0.05 in
both cases), whereas neither intracellular stage (amastigotes
and intracellular epimastigotes) derived from CHO-K1 cells
exhibited significant differences compared with the reference
stage (Fig. 10A). The enzymatic activities of TcP5CDH were
also assayed for all of the life cycle stages. Interestingly, the
activity profile correlated with its mRNA profile, with notable
differences between trypomastigotes and epimastigotes, amas-
tigotes and intracellular epimastigotes, and metacyclic trypo-
mastigotes and amastigotes (Fig. 10A) (p value 	 0.05). In all
three of these comparisons, both mRNA and enzymatic levels
were increased in the infective stage in comparison with the
epimastigote reference stage (6-fold). Although the differences
in specific activities were not significant between epimastigotes
and metacyclic trypomastigotes, our data showed a relation
between transcriptional and activity levels in all the stages ana-
lyzed (Fig. 10A). Notably, when the protein levels of TcP5CDH
were analyzed byWestern blotting, significant differences were
not observed (Fig. 10B) with the exception of the intracellular
stages (A and IE) compared with the other stages tested (Fig.
10B). Taken together, these data indicate a strong regulation of
TcP5CDH throughout the life cycle at least at the post-tran-
scriptional and post-translational levels, consistent with the
participation of an enzyme in a nodal metabolic pathway.
Physiological Role for P5C—Having confirmed that TcP5CDH
activity can be NAD(P)-dependent and that it is associated
with mitochondrial membranes, we addressed the ability of
parasite cells to use P5C as a nutritional source. To this end, we
subjected epimastigote forms to metabolic starvation by incu-
bating the cells in PBS supplemented or not with P5C to evalu-
ate their ability to survive duringmetabolic stress. Parallel incu-
bationswith othermetabolites, such as D-glucose and L-proline,
which are known to extend parasite survival under such condi-
tions, were run as controls. Notably, P5C synthesis yields a sta-
ble product in acidic medium (1 M HCl); thus, the pH must be
adjusted to values 
7.0 prior to the assay; otherwise, the cells
are unable to uptake P5C, which results in cell death (data not
shown). The fact that parasites can extend their life spans dur-
ing the conditions described above (Fig. 11A) indicates that
P5C is not only metabolized but can also be taken up from the
extracellular medium. Therefore, we tested whether P5C par-
ticipates in ATP production. We starved the cells (in PBS) for
24 h to deplete intracellular ATP stocks and further incubated
them in PBS in the presence and absence of P5C. PBS supple-
mented with proline was used as a control. The intracellular
ATP levels were restored in cells incubated with L-proline or
P5C (Fig. 11B), indicating the participation of P5C in energy
production. This activity was impaired in the presence of a
mitochondrial complex IV inhibitor (antimycin A), suggesting
that P5C-dependent ATP production was driven by oxidative
phosphorylation.
After observing that T. cruzi incorporates P5C from the
external media, and because TcP5CDH is up-regulated during
infective stages, we evaluated the P5C in the T. cruzi intracel-
lular cycle. To this end, we performed a similar experiment to
that described above by incubating metabolically stressed TCT
forms under increased concentrations of P5C. Treated para-
sites were used to infect CHO-K1 cells, and the number of TCT
forms released after the completion of their infective cycle (6th
day) was determined. As expected, the number of parasites
released from infected cells incubated in minimum media
(PBS SFB) was diminished by 50% (p	 0.05) compared with
those released from infected cells incubated in control media
(RPMI 1640 medium) (Fig. 11C). When the parasites were
incubated with the host cells (3 h at 37 °C) under different
concentrations of P5C, a dose-response effect on the number
of released parasites was observed (Fig. 11C). At 100M P5C,
no statistically significant differences were observed in the
trypomastigotes release between RPMI 1640 medium and
P5C-treated parasites, indicating that P5C can efficiently
revert the effect of metabolic stress on the parasite invasion
and infection. These data provide evidence of a physiological
role for TcP5CDH, likely associated with its mitochondrial
functions, and its natural substrate in either proliferative or
infective forms of T. cruzi.
TABLE 4
Proteins identified from themitochondrial samples after BNGE
Bands corresponding to the regions where recombinant TcP5CDHwas detected on
native gels (Fig. 6B) were excised fromBN gels (numbered 1–5 in Fig. 6B), treated as
described under “Experimental Procedures,” and analyzed by tandem MS/MS. For
simplicity, only some of the identified proteins are shown.
Sample
from
BNGE Protein name GI no.
Peptides
no.
1 Cytochrome c oxidase subunit IV 71667854 51
1 Cytochrome c oxidase subunit V 71412456 32
1 Cytochrome c oxidase subunit VI 71412400 30
5 Cytochrome c oxidase subunit VII 71661625 17
4 Cytochrome c oxidase subunit IV 71667854 94
4 Cytochrome c oxidase subunit V 71412456 14
4 Cytochrome c oxidase subunit VI 71412400 74
5 Cytochrome c oxidase subunit IV 71667854 53
5 Cytochrome c oxidase subunit V 71412456 55
3 Succinate dehydrogenase 5931575 22
3 Succinate dehydrogenase 71401706 10
5 Succinate dehydrogenase 5931575 203
1 1-Pyrroline-5-carboxylate dehydrogenase 71657117 7
2 1-Pyrroline-5-carboxylate dehydrogenase 71657117 4
3 1-Pyrroline-5-carboxylate dehydrogenase 71657117 4
4 1-Pyrroline-5-carboxylate dehydrogenase 71657117 5
5 1-Pyrroline-5-carboxylate dehydrogenase 71657117 17
1 -Subunit of mitochondrial processing
peptidase
71655600 12
1 -Subunit ATPase 71661631 47
3 -Subunit of mitochondrial processing
peptidase
71420779 6
2 Precursor of Reiske iron-sulfate protein 71655052 30
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DISCUSSION
L-Proline is a nonessential amino acid, with different
enzymes involved in its oxidation or biosynthetic routes
depending on the organisms. In eukaryotes, these enzymes are
located in themitochondria andmay participate in other redox
processes that occur inside this organelle (70). Although the
TcP5CDH N terminus could not be accurately predicted as an
mTPusing conventional bioinformatic tools, a detailed analysis
revealed anN-terminal region (MLRR and FAFAYAmotifs and
an -helix spanning the mitochondrial membrane) with pro-
tein fingerprints that are characteristic of an mTP for mito-
chondrial proteins in trypanosomes (67). Once imported, this
mTP can be removed by mitochondrial peptidases (Gi:
71655600, 71420779 in Table 4), as indicated by MS data from
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our mitochondrial preparations. However, because migration
of TcP5CDH in mitochondrial samples differs (upper band in
Fig. 8C) from that observed in total lysates, either the cleavage
of mTP does not occur or TcP5CDH undergoes a post-transla-
tional modification when associated with the mitochondria.
Consistent with the subcellular localization of TcP5CDH, a
proteomic analysis performed on mitochondrial fractions of T.
brucei reportedly detected TbP5CDH exclusively in protein
samples derived from inner mitochondrial membranes (71). In
this compartment, an interaction with mitochondrial complex
IV has been suggested (72), and a thioacylation event (with the
addition of a palmitic acid) in the cysteine residues of
TbP5CDHhas also been reported (73). Similarly, we observed a
co-localization of P5CDH and complex IV in our proteomic
analysis, which, although not demonstrative, may be indicative
of an interaction between these two complexes within high
molecular weight fractions (Fig. 8B and Table 4).
Because TcP5CDH activity was stimulated (5-fold) upon the
addition of Triton X-100 in mitochondrial vesicles and NAD
diffuses freely through the MOM but not in the MIM (74), we
can assume that TcP5CDH is exposed on either the inner face
of the MOM or the external face of the MIM. Basal TcP5CDH
activity was detected in our mitochondrial preparations in the
absence of detergent. Therefore, we propose that TcP5CDH
interacts withMIM, and its catalytic site is likely exposed to the
mitochondrial matrix (Fig. 12). This latter possibility is consis-
tent with data analyzed from the T. brucei mitochondrial pro-
teome (75). Along with our data for T. cruzi, this evidence sup-
ports the existence of P5CDHas a component ofmitochondrial
membranes, which can be involved in redox processes within
the mitochondrion of this unique parasite.
As described above, TcP5CDH interacts with mitochondrial
membranes. This interaction is most likely mediated by an
-helix domain (Phe198–Gly215), the structure of which is dis-
rupted by the Pro211 residue, as observed in the deduced amino
acid sequence. The detection of TcP5CDH under native condi-
tions inmitochondrial samples solubilizedwith different deter-
gents suggests that the active form is presentwithin the parasite
as an oligomer. The treatment of mitochondrial lysates with
DIG (a mild detergent) (76) followed by Western blot analysis
revealed a single band (with an apparent size of 380 kDa) when
probed using anti-TcP5CDH. However, when this sample was
further analyzed by conventional SDS-PAGE (two-dimen-
sional), two reactive bands with molecular masses that were
equivalent to themonomeric formofTcP5CDHwere observed.
The higher band was not detected by BNGEWestern blot anal-
ysis, which may be explained by the following factors: (i)
TcP5CDH forms protein complexes with other mitochondrial
components that interfere with epitope exposure and are rec-
ognized by anti-TcP5CDH, or (ii) the number of blotted pro-
teins with thismolecularmass was below the sensitivity thresh-
old of detection for the antibody. Nevertheless, we confirmed
FIGURE 9. Subcellular localization of TcP5CDH. A, TcP5CDH immunolabeling in the predominant life stages of T. cruzi. Axenic forms from E and M forms, A,
Ie, and TCT derived from infected CHO-K1 cells (iCHO) were analyzed by microscopy. The cells were preincubated with 50 nM MitoTracker-CMXROS (MitoT)
(red) and fixed on polylysine-coated coverslips for subsequent immunostaining with anti-TcP5CDH (1:100), followed by secondary staining with AlexaFluor-
488goat anti-mouse IgG (H L) (Invitrogen) (1:400). TheDNAwas stainedusingHoechst-33258 (1:5000) (blue). For the iCHOassay, CHO-K1 cellswere cultured
on 24-well plates containing an embedded glass coverslip, which were subsequently used for TCT infection. After the 3rd day of infection, the cells were
washed twice with PBS/BSA (2% w/v) and incubated with MitoTracker, followed by immunostaining with anti-TcP5CDH and Hoechst as detailed above. The
resulting images were merged using ImageJ software. The arrows indicate the co-localization of all the three probes within a region proximal to the kineto-
plastid DNA. B,Western blot analysis from digitonin-titrated fractions. Epimastigotes were selectively permeabilized with increased digitonin concentrations
(0–5 mg ml1), and the resulting supernatants (S) and pellets (P) were analyzed. All of the samples (40 g per lane) were subjected to SDS-PAGE (10%),
transferred to nitrocellulose membranes, and probed with polyclonal antibodies raised against TcTAT (mass 45 kDa, cytosolic marker), glyceraldehyde-3-
phosphate dehydrogenase (TcGAPDH) (mass 39 kDa, glycosomal marker), proline dehydrogenase (TcProDH) (mass 65 kDa, mitochondrial marker), and
TcP5CDH as indicated. C, biochemical assays for the subcellular localization of TcP5CDH. Resulting samples from digitonized epimastigotes were also used as
enzymatic sources in biochemical assays. The enzymatic activities of pyruvate kinase (E) (cytosolmarker), hexokinase (*) (glycosomalmarker), citrate synthase
(Œ) (mitochondrial marker), and TcP5CDH (f) were determined for all of the resulting fractions (S and P). Values plotted on the graph correspond to the ratio
between activities on S and P S and are expressed as a percentage of the enzyme.
FIGURE 10. Analysis of TcP5CDH over distinct parasite life stages. A, expression levels of TcP5CDH in the predominant life stages of T. cruzi. Noninfected
CHO-K1 cells served as controls. Total cell-free extracts from each parasitic stage were used as enzymatic sources in the TcP5CDH activity assay (left axis). RNA
preparations from the stagesnotedabovewereused inquantitative real timePCRassays (quantitative RT-PCR). Comparisonswereperformedusing the2Ct
method and normalized relative to TcGAPDH expression levels. Values plotted correspond to the levels of fold change compared with the indicated epimas-
tigote stage (right axis). The differences among the samples were calculated using one-way analysis of variance and Tukey’s post test considering a p value	
0.05 as significant. B, Western blot analysis for TcP5CDH levels in the above-listed parasitic life stages. Protein sample preparations are described under
“Experimental Procedures,” and equivalent amounts (40 g) of each preparation were loaded per lane. The samples were subjected to SDS-PAGE (10%),
transferred to nitrocellulose membranes, and probed with polyclonal antibodies raised against TcP5CDH (1:2000) and TcGADPH (1:2500). The latter did not
react with GAPDH isoforms from the CHO-K1 cells used in our assay conditions.
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the presence of TcP5CDH in samples compatible with this
highermolecular size throughMSdata analysis. This co-migra-
tion with respiratory chain complexes further implicates
TcP5CDH as a mitochondrial membrane-bound component
and may be an indication of other protein associations. This
particular TcP5CDH migration under nondenaturing condi-
tions was also confirmed when the recombinant isoform was
resolved by BNGE. The multimeric structure of functional
TcP5CDH was also confirmed by SEC, DLS, BNGE, and SAXS
analysis. These results indicated a predominantly hexameric
arrangement. This is consistent with previous structural data
describing a hexameric conformation (25), suggesting that
TcP5CDH exists as an oligomer. The enzyme bound to mito-
chondrial membranes exhibited either a hexameric conforma-
tion or a protein super-complex arrangement compatible with
a dimer of hexamers. These data were also supported bymolec-
ular masses obtained for the recombinant protein from SEC,
DLS, and BNGE, which were compatible with this assumption.
Structural studies have reported different oligomeric states
for P5CDHs (25–27). In archaea, P5CDH forms a homohex-
amer in its ligand-free form (25). In contrast, a ring-shaped
tetramer was reported for bacteria (27). In the latter group,
proline dehydrogenase and P5CDH are not separate enzymes
but, rather, exist as a single enzyme that catalyzes the entire
conversion of proline into glutamate. Both catalytic domains
are arranged in a single bifunctional flavoenzyme in which pro-
line oxidation to glutamate occurs through a P5C-channeling
mechanism (27). Thus, the separation of these domains into
two distinct enzymes might represent an early evolutionary
process.
The affinity of TcP5CDH for GS (produced from synthetic
P5C), as reflected by low Km values (at a scale of micromolars),
reveals the ability ofT. cruzi cells to efficiently convert P5C into
glutamate, the onlymetabolic fate of P5C in this organism. This
finding precludes the accumulation of P5C within the cell,
which could otherwise result in an oxidative imbalance and
lethality for the parasite. Indeed, yeast cells that are unable to
express a functional P5CDH (defective for the PUT2 gene)
exhibited an intracellular accumulation of P5C andwere unable
to grow in selective media in which proline was the only nitro-
gen source. It has been well described that reactive oxygen spe-
cies are produced inPUT2 yeasts under these conditions, dra-
FIGURE 11. Functional test of P5C in replicative and infective forms of T. cruzi. A, viability test in metabolically stressed cells (over 24 h) in the presence of
singlenutritional sources (3mM) as indicated.After the incubationperiod, the cellswerewashedoncewithPBSand incubated (4h)withMTT reagent in viability
assays. Because theP5Cpurificationmethodwasperformed in acidmedium (HCl), thepHof themediumwas adjusted (7.2)with KOHprior to usewith the cells.
An additional control of P5C-eluting agent (HCl) was also used. Absorbance ratio (590–695 nm) values were converted into percentages of cell viability using
LIT as a control. B, determination of ATP levels in epimastigote forms after metabolic starvation. Intracellular ATPwas depleted by incubation (30 h at 28 °C) in
PBS buffer, followed by a recovery time (1 h) with 1mM of single catabolic substrates. An additional treatment in the presence of P5C plus 0.5M antimycin-A
(AA) (a respiratory chain complex IV inhibitor) was also performed. Next, the cells were lysed, and ATP content was determined using a luminescence-based
assay following themanufacturer’s protocols. The ATP content is expressed relative to cells under normal conditions (as 100%, grown in LITmedium). C, effect
of P5C as a catabolic substrate was also tested for the infective TCT forms. iCHO cells were incubated (3 h) under normal (RPMI 1640medium) and conditional
media (PBS FCS or PBS P5C), and the number of parasites released into the supernatant (after the 6th day) was determined by hemocytometer counting.
No significant (ns) differences were detected when RPMI 1640 medium was compared with PBS 100 M P5C, as indicated by one-way analysis of variance
followed by Bonferroni’s multiple comparison test (*, p	 0.05). Bars in the graph represent the results for three independent replicates (n 3).
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matically affecting cell viability (32). We confirmed this
characteristic in our functional complementation assay using
PUT2mutant yeast in which P5C accumulates intracellularly,
and cell growth is impaired under minimal proline medium
conditions. Although we have not addressed the issue of
TcP5CDH trafficking inside yeast cells, we assumed that
TcP5CDHwas processed via a mechanism that was as efficient
as that used for T. cruzi cells.
Proline breakdown in T. cruzi occurs through two oxidation
steps (7). First, a dimeric mitochondrial enzyme is catalyzed by
a proline dehydrogenase and oxidizes the proline in P5C cou-
pled with a reduction in FAD. The electrons are channeled into
the electron transport chain through coenzyme Q and trans-
ferred downstream via an identical route as that used in succi-
nate oxidation by succinate dehydrogenase at complex II. Next,
TcP5CDH oxidizes GS to glutamic acid, and NAD/NADP
is concomitantly reduced. This process also occurs in themito-
chondria, where the entire proline oxidation process is known
to occur during ATP production (9, 10).
In water, P5C exists in equilibrium with GS, and NMR data
indicate that the imino-form of P5C predominates at pH 5.8
(pKaHimino  6.7; pKaCOOH  1.8) (19, 63, 79, 80). DFT calcu-
lations also indicate that the imino-protonated cyclic form
(P5C) is thermodynamically preferred over the zwitterionic
form of GS. Accordingly, crystallographic data indicate that
GS is the substrate of T. thermophilus1-pyrroline-5-carbox-
ylate dehydrogenase and that the nucleophilic attack of the
thiol portion of Cys336 to the GS carbonyl yields an interme-
diate hemithioacetal, which is subsequently converted to gluta-
mate via NAD-mediated hydrolysis (25, 66). Assuming that
the active site of the T. cruzi P5CDH is similar to that of T.
thermophilus, the deprotonation of the –SH group of the cys-
teine residue (whose pKa is unknown but can be assumed to be

6–8) (81) might be crucial to the oxidation of GS because
the thiolate is a more efficient nucleophile than its correspond-
ing protonated form. This hypothesis is corroborated by the
fact that the optimal pH values reported for P5CDHs from
other species are similar (25, 27, 82) and can explain the lack of
activation for the nucleophilic attack of the thiol group
reported by Inagaki et al. (25). In other words, although the
cyclic form (P5C) is thermodynamically more favorable, this
characteristic is irrelevant for the overall oxidation mechanism
because the enzymatic oxidation of GS to glutamate is
assumed to be rapid and irreversible (23, 82). As a consequence,
GS is not expected to accumulate. Furthermore, the intracel-
lular pH in the amastigote and TCT forms of T. cruzi is 7.3, a
condition that favors the enzymatic conversion of GS into
glutamate (83).
The reaction catalyzed by TcP5CDH was dependent on
NAD or NADP reduction, and the affinity constants (Km
values) measured in mitochondrial lysates or TcP5CDH-His6
were similar. However, the Km value for NAD in TcP5CDH-
His6 was higher (72.3  14.1 M) than that calculated for
NADP (342  140 M). Furthermore, the catalytic efficiency
(kcat/Km) exhibited forNADPwas reduced in both cases, indi-
cating that in themitochondria of the parasite, TcP5CDH, pro-
duces reduced equivalents (NADH and NADPH) that can be
used in other biochemical processes (discussed below). The
affinity for GS under saturating concentrations of NAD was
comparable in both enzymatic preparations, but the differences
found in terms of catalytic efficiency can be interpreted as either a
consequence of additional NAD-dependent enzymes or
TcP5CS, which interconverts glutamate to P5C via GS. The Km
values determined herein for GS were consistent with those
reported from orthologs in other organisms (25, 84).
The activity of TcP5CDHwas dependent on the temperature
of the reaction and was optimal at 45 °C, which is higher than
the temperatures experienced by the parasite during its life
cycle through different hosts (which range from environmental
temperatures in the insect vector up to 37 °C). However, similar
FIGURE12.Schematicof themitochondrialprolinemetabolicpathway inT. cruziand its role inbioenergetics.Prolinemustbe takenup fromextracellular
medium into mitochondria, where it is further oxidized into P5C by FAD-dependent TcProDH concomitantly with the production of FADH2. Next, the P5C is
spontaneously converted into GS, which is enzymatically converted to L-Glu. The TcP5CDH localizes within the inner mitochondrial membrane (IMM) and
faces the matrix space, where the conversion of GS into glutamate occurs at neutral pH. The glutamate produced can be deaminated into -ketoglutarate
(-KG) and further oxidized in the tricarboxylic acid cycle (TCA), where substrate level phosphorylation can occur at a sufficient succinyl-CoA synthetase level
(110). Because the function of the NADH:ubiquinone reductase complex appears limited in T. cruzi (69, 78), NADH can be reoxidized by fumarate reductase
(FMR) toproduce succinate.Next, e contained inFADH2andNADHare transferred (dashedarrows) to theubiquinone (UQ) pool toa similardegreeas succinate
dehydrogenase (SDH), promoting the synthesis of ATP by proton F0F1-ATP synthase via the oxidative phosphorylation process. P5C-dependent ATP produc-
tion is susceptible to inhibitionby antimycin-A (AA) at the level of the cytochrome c reductase complex level, thus supporting the abovedescribed assumption.
However, subsequent protein associations within the mitochondria of this parasite cannot be excluded (gray arrow).
Proline Catabolism in Trypanosoma cruzi
MARCH 20, 2015•VOLUME 290•NUMBER 12 JOURNAL OF BIOLOGICAL CHEMISTRY 7785
results have been described for enzymes that are insensitive to
thermal inactivation (85). Nonlinear Arrhenius plots can be
observed even if the T range is not large, as has been observed
for the enzymatic oxidation of GS (86, 87). This pattern is
particularly evident for many enzymatic biochemical reactions
occurring in membranes. Thus, different steps of the complex
reaction may become rate-limiting at different temperatures
andmediumpH.Alternatively, there areT-induced phase tran-
sitions within the membrane (86, 87). The result reported here
is consistent with the complex reaction mechanism involving
the presence of the cofactor NAD (85).
Our observations regarding TcP5CDH expression show that
this enzyme is developmentally expressed throughout the par-
asite life cycle. An integrated analysis of mRNA, protein levels,
and enzymatic rates allowed us to conclude TcP5CDH is up-
regulated during bothM- and T-infective stages. The apparent
discordance betweenmRNA and protein levelsmight be attrib-
uted to post-transcriptional regulation, a mechanism that has
been well described for trypanosomatids (88). Such differential
expression of TcP5CDH is likely associated with themetabolite
availability faced by T. cruzi in different hosts. In kissing bugs,
L-proline was reported to be an abundant amino acid in tissue
fluids and urine (89, 90). The predominance of proline in the
intracellular pool of amino acids in T. cruzi epimastigotes has
also been reported (91). In a comprehensive proteomic analysis
of the T. cruzi secretome, proline-related enzymes have been
described (92). Proline racemase converts D-proline into L-pro-
line and acts as a host B-cell mitogen (93). The prolyl oligopep-
tidase hydrolyzes large substrates such as fibronectin andnative
collagen, which can fulfill proline requirements within the
extracellular matrix during the mammal host cell invasion
process (94). This redundancy of proline as an energy source
has been associatedwith physiological processes such as in vitro
metacyclogenesis (95) and differentiation during the intracel-
lular stages (13). Indeed, proline is the only amino acid that is
sufficient forT. cruzi to generate theATP levels required for the
invasion of mammal host cells (12). These previously reported
data, along with our observations, indicate that proline metab-
olism is a crucial part of theT. cruzi infection process, although
the role of proline metabolism does not appear to be limited to
the generation of ATP. In this regard, we propose that compo-
nents of proline metabolismmight be involved as regulatory or
signaling factors duringT. cruzi infection. As these factorsmust
be occasionally secreted or exposed on the cell surface when
host interactions occur and as we observed that the TcP5CDH
immunolabeling profile surrounds the cells in the TCT forms
and that P5C can supply the energy required for the infectivity
process in CHO-K1, it is conceivable that TcP5CDH functions
as a metabolic enzyme that interacts with components of the
mammal host cell during the infection process. InCryptococcus
neoformans, a pathogenic yeast, PUT2 is required for the opti-
mal production of major cryptococcal virulence factors, and in
mice, infection with a PUT2 mutant was determined to be
nonvirulent (96). Another study has shown that the immune
response underlying pneumococcal colonization affects Staph-
ylococcus aureus colonization and identified S. aureus P5CDH
as a target in a cross-reactive antibody response (97). In
trypanosomatids, the participation of enzymes with pivotal
roles beyond their canonical metabolic functions has been
reported.T. brucei responds to citrate exposure at the initiation
of its life cycle during transmission to the tsetse fly (98). Fur-
thermore, in Leishmania parasites, enolase and arginase repre-
sent examples of enzymes that participate in the infection pro-
cess or pathogenesis (99, 100).
Structural data on TcP5CDH, together with its mitochon-
drial membrane localization and up-regulated activity during
infective stages, led us to hypothesize additional functions for
this enzyme beyond the production of glutamate. We have
observed that TcP5CDH oxidizes P5C in a process that is cou-
pledwithNAD(P)H generation, both of which are necessary for
other biological processes. For example, NADHmight promote
oxidative phosphorylation, generating the proton-driven force
in the form of an electrochemical potential that can drive the
synthesis of ATP (101). Moreover, NADPH serves as a cofactor
for trypanothione reductase (102). Indeed, we have observed
that P5C can serve as a viable energy source in theATP produc-
tion, which was supported by our data showing that antimycin
A inhibits this process. The energy can be generated from two
possible routes. (i) NADH serves as a substrate for components
of the respiratory chain, and therefore, ATP is produced
through the electron respiratory chain. Despite the presence of
mitochondrial complex I that is limited in functionality in T.
cruzi, NADH can be further reoxidized by fumarate reductase
(103). (ii) Alternatively, TcP5CDHproduces glutamate that can
be further deaminated to-KG,which can be oxidized, produc-
ing CO2 and three molecules of NADH, thus enabling extra
ATP synthesis. Next, the two-step oxidation of proline pro-
duces FADH2 andNADHthat can feed the oxidative phosphor-
ylation driving ATP synthesis (Fig. 12). P5C can be produced
and secreted to the extracellular medium by mammalian cells
(104, 105). Thus, P5C could be used as an energy source by
other cells naturally exposed to these metabolites.
Proline synthesis in T. cruzi is operative.3 T. cruzi is able to
synthesize proline from glutamate by mean of a bifunctional
glutamyl kinase P5C synthetase (UniprotKB access code
K4E0F1). P5C is further reduced to proline by P5C reductase
(K4EAX2). Hence, the tight regulation of intracellular proline
and intermediate pools and related enzymesmust be present in
T. cruzi throughout its life cycle to avoid futile conversions. As
proline is oxidized within the mitochondria of T. cruzi, a trans-
port system likely functions to uptake this amino acid into the
organelle. Glutamic acid at physiological pH (7.2) exists in a
deprotonated form (106). Interestingly, this glutamic acid is
actively taken up from the extracellular medium via a single
transporter (107). However, several intracellular sources of the
intramitochondrial synthesis of glutamate by enzymatic action
have been demonstrated (46, 47, 108). In addition to the oxida-
tion of GS (catalyzed by TcP5CDH), glutamate can be enzy-
matically generated from the transamination of L-alanine or
L-aspartate, the conversion of L-histidine, or the reductive ami-
nation of -ketoglutarate (-KG). The latter step is reversible,
where-ketoglutarate acts as an intermediatemetabolite of the
Krebs cycle (109). These glutamate-related enzymes have been
3 L. Marchese, K. Olavarria, B. S. Mantilla, and A. M. Silber, unpublished data.
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detected in both the mitochondria and the cytosol of T. cruzi
(46, 47). Moreover, glutamate might also be converted to glu-
tamine, which is a relevant precursor for amino sugar metabo-
lism and conversion into N-acetylglucosamine. We have also
observed that the overexpression of TcP5CDH can stimulate
the enzymatic activity of glutamine synthetase.3 Therefore, the
glutamate generated in T. cruzi represents an example of an
amino acid that exhibits multiple roles beyond protein synthe-
sis. Taken together with the up-regulation of TcP5CDH in the
infective forms and with its participation in the respiratory
chain to produceATP, our data highlight this enzymatic step as
crucial for T. cruzi viability in both replicative and infective
forms.
Conclusions—Here, we demonstrate that the pathogenic spe-
cies T. cruzi expresses a functional TcP5CDH enzyme. Our
enzymatic assays for TcP5CDH demonstrate that glutamate is
irreversibly produced from its P5C-opened form GS, which is
coupled to the reduction of either NAD orNADPwithin the
mitochondria of T. cruzi. Functional assays using mitochon-
drial preparations from T. cruzi revealed that TcP5CDH is cat-
alytically active as a membrane-bound enzyme. The kinetic
parameters for TcP5CDH and its cofactors are consistent with
those observed within the mitochondrial fractions of this para-
site, suggesting a high catalytic efficiency to oxidize GS.More-
over, TcP5CDH is present in a hexameric state, and its interac-
tion with mitochondrial membranes is presumably facilitated
by an -helix domain.
Mitochondrial TcP5CDH produces glutamate, concomi-
tantly providing reducing equivalents, which are further used to
synthesize ATP via the electron transport chain. In particular,
TcP5CDH is differentially up-regulated during infective stages.
Overall, we postulate that proline metabolism in T. cruzi rep-
resents an efficient mechanism that fulfills energy require-
ments throughout the life cycle of this parasite. This strategy is
correlated with substrate availability in the different hosts of
the parasite. Because of the high substrate specificity that
TcP5CDH exhibits for GS, as well as its developmental and
mitochondrial functions, we propose that this enzymatic step is
crucial for the persistence of this parasite during infectious
stages.
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